Top

Arlene M. Correa, Ph.D.

Department of Thoracic and Cardiovascular Surgery, Division of Surgery

About Dr. Arlene M. Correa

Dr. Arlene M. Correa was born in San Juan, Puerto Rico. She obtained her Master's degree in Mathematics at the University of Puerto Rico and her Ph.D. in Biometry with a minor in Epidemiology and Behavioral Sciences from The University of Texas - Houston Health Science Center, School of Public Health. Dr. Correa joined the Department of Thoracic and Cardiovascular Surgery at The University of Texas MD Anderson Cancer Center, in July 2000 as a Statistical Analyst and quickly excelled to the level of Instructor in August 2001. Her expertise, drive and compassion let her ease through the ranks to Assistant Professor in September 2004 and Associate Professor in September 2011.

Dr. Correa has been instrumental in the development, migration, and expansion of the department's clinical database. She has also developed many sub-set databases and assists the faculty and fellows with research projects. Her research interests are esophageal and lung cancer, and survival analysis. When she isn't working, she enjoys spending quality time with her family.

Primary Appointment

Associate Professor, Department of Thoracic and Cardiovascular Surgery - Research, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2000	The University of Texas - Houston Health Science Center, School of Public, Houston, Texas, US, Biometry with minor in Epidemiology and Behavioral Sciences, Ph.D
1995	University of Puerto Rico, Río Piedras, PR, Mathematics, M.S
1993	University of Puerto Rico, Río Piedras, PR, Mathematics, BS
1991	University of Puerto Rico at Bayamón, Bayamón, PR, Mathematics, AS

Postgraduate Training

1999-2000	Teaching Assistant, UT Health Science Center, Houston, Texas
1996-1999	Graduate Research Assistant III, Center for Health Promotion Research and Development, School of Public Health, UT Health Science Center, Houston, Texas
1995-1996	Statistics, 12 Ph.D. credits, The University of Texas at Dallas, Dallas, Texas
1994-1995	Teaching Assistant, Department of Mathematics, University of Puerto Rico, Río Piedras
1994-1994	Teaching Assistant, Mathematics, University of Puerto Rico, Río Piedras
1993-1993	Research Assistant, Mathematics, University of Puerto Rico, Río Piedras
1992-1992	Precalculus Laboratory Instructor, Mathematics, University of Puerto Rico, Río Piedras

Experience & Service

Faculty Academic Appointments

Assistant Professor (NTRA), Department of Thoracic and Cardiovascular Surgery - Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2011

Instructor, Department of Thoracic and Cardiovascular Surgery - Research, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2001 - 2004

Teaching Assistant, The University of Texas Health Science Center, Houston, TX, 1999 - 2000

Graduate Research Assistant, Department of Center for Health Promotion Research and Development, School of Public Health, The University of Texas Health Science Center, Houston, TX, 1996 - 1999

Other Professional Positions

Senior Statistical Analyst, The University of Texas MD Anderson Cancer Center, Houston, TX, 2001 - 2001

Statistical Analyst, The University of Texas MD Anderson Cancer Center, Houston, TX, 2000 - 2001

Adjunct Faculty, The University of Houston-Clear Lake, Houston, TX, 1999 - 1999

Adjunct Faculty, Collin County Community College, Preston Ridge Campus, Frisco, TX, 1996 - 1996

Research Assistant, University of Puerto Rico, Rio Piedras, 1993

Pre-calculus Laboratory Instructor, University of Puerto Rico, Rio Piedras, 1992

Honors & Awards

2001	Delta Omega Honor Society
1999 - 2000	Richard D. Remington Scholarship
1991	Natural Sciences Medal
1991	Magna Cum Laude
1991 - 1993	Who's Who Among Students in American Universities & Colleges
1989 - 1993	Dean's Honor Roll

Grant & Contract Support

Date:	2023 - 2028
Title:	University of Texas PDX Development and Trial Center: Core A: Administrative Core
Funding Source:	NIH/NCI
Role:	Statistician
ID:	U54CA224065

Date:	2020 - 2024
Title:	Understand the function of PKR and target it for lung cancer therapy
Funding Source:	NIH/NCI
Role:	Co-I
ID:	GRANT12941937

Date:	2020 - 2022
Title:	Venothromboembolism Risk Stratification in Thoracic Surgery Patients: Does it identify high-risk patients?
Funding Source:	NIH/NCI
Role:	Co-I
ID:	FP00009417

Date:	2019 - 2021
Title:	PKR prevents misfolded PrP proteins release through multivesicular bodies (MVB)/exosomes
Funding Source:	Department of Defense (DOD)
Role:	Collaborator
ID:	W81XWH-18-LCRP-IDA

Date:	2019 - 2024
Title:	Targeting PKR and EphA2 for personalized lung cancer therapy
Funding Source:	NIH/NCI
Role:	Collaborator

Date:	2019 - 2024
Title:	Developing MPR and biomarker in NSCLC tumors receiving neoadjuvant chemotherapy
Funding Source:	NIH/NCI
Role:	Co-I
ID:	GRANT12629380

Date:	2018 - 2023
Title:	PKR-guided personalized therapy for lung cancer
Funding Source:	NIH/NCI
Role:	Co-I
ID:	R01CA229214

Date:	2018 - 2022
Title:	Impact of PKR on misfolded prion proteins and exosomes release in lung cancer
Funding Source:	NIH/NCI
Role:	Co-I
ID:	R01CA225821

Date:	2017 - 2023
Title:	University of Texas PDX Development and Trial Center - Admin Core
Funding Source:	NIH/NCI
Role:	Statistician
ID:	1U54CA224065

Date:	2017 - 2021
Title:	Impact of PKR prognosis in early stage in lung cancer
Funding Source:	NIH/NCI
Role:	Co-I

Date:	2017 - 2020
Title:	Immunogene Therapy for Cancer
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-I
ID:	DP170013

Date:	2016 - 2019
Title:	Prognostic biomarkers for early stage lung cancer
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Collaborator

Date:	2016 - 2021
Title:	Using Patient Derived Xenografts to Fight Cancer in Texas
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Data Manager

Date:	2016 - 2021
Title:	miRNA in Lung Cancer
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Biostatical Analyst

Date:	2016 - 2020
Title:	Identifying KRAS Synthetic Lethal Targets Through innovative Screening Systems in Clinically Relevant Cancer Models
Funding Source:	NIH/NCI
Role:	Collaborator

Date:	2016 - 2020
Title:	Identifying KRAS Synthetic Lethal Targets through Innovative Screening Systems in Clinically Relevant Cancer Models
Funding Source:	NIH/NCI
Role:	Collaborator

Date:	2014 - 2020
Title:	Single Arm Study of Sterotactic Ablative Radiotherapy (SABR) for Patients with Stage I Non-small Cell Lung Cancer
Funding Source:	Varian Medical System
Role:	Biostatistician

Date:	2012 - 2016
Title:	Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis
Funding Source:	NIH/NCI
Role:	Co-I

Date:	2010 - 2015
Title:	Synergism of nanoparticles with molecular ligands for cancer imaging and therapy
Funding Source:	NIH/NCI
Role:	Collaborator

Date:	2010 - 2012
Title:	Mda-7 nanoparticle therapy for ovarian cancer
Funding Source:	NIH/NCI
Role:	Biostatistician

Date:	2010 - 2014
Title:	Nanoparticle-based imaging and therapy enablers for lung cancer
Funding Source:	CPRIT - Cancer Prevention Research Institute of Texas
Role:	Collaborator

Date:	2009 - 2011
Title:	Use of RAR-B2/RAR-B4 expression ratio as a biomarker in early detection and prognosis of esophageal cancer
Funding Source:	NIH/NCI
Role:	Collaborator

Date:	2009 - 2011
Title:	Cost-effectiveness of mediastinal staging strategies in patients with lung cancer
Funding Source:	NINR – National Institute of Nursing Research – ARRA Challenge Grant – RFA- OD-09-003
Role:	Biostatistician

Date:	2009 - 2011
Title:	Pulmonary risk factors and quality of life following lung cancer surgery
Funding Source:	NCI-ARRA Challenge Grant
Role:	Biostatistician

Date:	2009 - 2011
Title:	Genetic Markers on Chromosomes 1q in progression of Barrett’s Esophagus
Funding Source:	NIH/NCI
Role:	Statistical Analyst

Date:	2008 - 2009
Title:	Predictive models to identify risk factors associated with surgical outcomes among thoracic surgical oncology patients
Funding Source:	Robert Wood Johnson Foundation
Role:	Co-I

Date:	2008 - 2013
Title:	The University of Texas SPORE in Lung Cancer, Core A - Administrative Core
Funding Source:	NIH/NCI
Role:	Other Significant Contributor
ID:	P50 CA70907

Date:	2007 - 2010
Title:	PKR mediates a chemo-and radio-resistance in cancer cells
Funding Source:	NIH/NCI
Role:	Biostatistician
ID:	1 RO1 CA124388-01A1

Date:	2007 - 2010
Title:	Enhancement of Ad-mda7 mediated killing by inhibiting AKT pathway
Funding Source:	NIH/NCI
Role:	Biostatistician
ID:	RO1 CA124388

Date:	2007 - 2012
Title:	PROSPECT - Profiling of resistance patterns & oncogenic signaling pathways in evaluation of cancers of the thorax and therapeutics target identification. - Project 2: Tumor Molecular profiles in patients with operable non-small cell lung cance (NSCLC): impact on stage, prognosis, and relapse pattern
Funding Source:	Department of Defense (DOD)
Role:	Other Significant Contributor
ID:	W81XWH-07-1-0306

Date:	2003 - 2008
Title:	Assessment and Management of Symptoms Following Curative Surgery for NSCLC
Funding Source:	American Cancer Society
Role:	Collaborator
ID:	RSGPB-030244-01-PBP

Date:	2002 - 2006
Title:	TARGET (Translational Approaches for the Reversal, Genetic Evaluation and Treatment) of Lung Cancer - Proejct 4 - Prognostic role of hypermethylation of the death-associated protein (DAP) kinase and p16 gene promoters in early-stage non-small cell lung cancer
Funding Source:	Department of Defense (DOD)
Role:	Co-I
ID:	DAMD17-02-1-0706

Date:	2002 - 2006
Title:	Expression of the TRAIL Gene for Cancer Therapy
Funding Source:	NIH/NCI
Role:	Research Instructor
ID:	R01 CA092487

Selected Publications

Peer-Reviewed Articles

Camacho L, Chu CK, Mitchell MP, Nguyen T, Correa A, Mericli AF. Oncoplastic Reconstruction in the Setting of Prior Cosmetic Augmentation. Plast Reconstr Surg 154(5):919-928, 2024. e-Pub 2024. PMID: 38376232.
Deboever N, Correa AM, Feldman H, Eisenberg M, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WL. Early Interventional Treatment of High Output Chyle Leak After Esophagectomy is Associated With Improved Survival. Ann Surg 280(1):91-97, 2024. e-Pub 2024. PMID: 38568206.
Goltsov AA, Maru DM, Katkhuda R, Duose DY, Luthra R, Correa AM, Wang F, Futreal PA, Hofstetter WL. ANPEP/CD13 Expression as a Marker of Lymphovascular Invasion and Survival in Esophageal Adenocarcinoma. Ann Thorac Surg 118(1):241-251, 2024. e-Pub 2024. PMID: 37806335.
Krijgh DD, Smith JM, Tilney G, Lyu H, Traweek RS, Witt RG, Roubaud MJ, Correa AM, Roland CL, Mericli AF. Identifying risk factors and analyzing reconstructive outcomes in patients with lower-extremity soft-tissue sarcoma. J Plast Reconstr Aesthet Surg 89:174-185, 2024. e-Pub 2024. PMID: 38199219.
Shah SA, Zhang Y, Correa AM, Hijaz BA, Yang AZ, Fayanju OM, Cerullo M. Rates of price disclosure associated with the surgical treatment of early-stage breast cancer one year after implementation of federal regulations. Breast Cancer Res Treat 203(2):397-406, 2024. e-Pub 2024. PMID: 37851289.
Deboever N, Correa AM, Feldman H, Mathur U, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Walsh GL, Vaporciyan AA, Antonoff MB, Rajaram R. Disparities in early-stage lung cancer outcomes at minority-serving hospitals compared with nonminority serving hospitals. J Thorac Cardiovasc Surg 167(1):329-337.e4, 2024. e-Pub 2024. PMID: 37116780.
Sheshadri A, Rajaram R, Baugh A, Castro M, Correa AM, Soto F, Daniel CR, Li L, Evans SE, Dickey BF, Vaporciyan AA, Ost DE. Association of Preoperative Lung Function with Complications after Lobectomy Using Race-Neutral and Race-Specific Normative Equations. Ann Am Thorac Soc 21(1):38-46, 2024. e-Pub 2024. PMID: 37796618.
Pataer A, Weissferdt A, Correa AM, Vaporciyan AA, Sepesi B, Heymach JV, Berezowska S, Cascone T, Swisher SG. Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy. JTO Clin Res Rep 3(11):100420, 2022. e-Pub 2022. PMID: 36389133.
Rice D, Rodriguez-Restrepo A, Mena G, Cata J, Thall P, Milton D, Correa A, Woodard T, Antonoff M, Hofstetter W, Roth J, Sepesi B, Swisher S, Walsh G, Vaporciyan A, Mehran R. Matched Pairs Comparison of an Enhanced Recovery Pathway Versus Conventional Management on Opioid Exposure and Pain Control in Patients Undergoing Lung Surgery. Ann Surg 274(6):1099-1106, 2021. e-Pub 2020. PMID: 32229762.
Luc JGY, Corsini EM, Mitchell KG, Correa AM, Turner NS, Vaporciyan AA, Antonoff MB. Effect of Operating Room Personnel Generation on Perceptions and Responses to Surgeon Behavior. Am Surg 87(12):1934-1945, 2021. e-Pub 2021. PMID: 34553636.
Song S, Chen Q, Li Y, Lei G, Scott A, Huo L, Li CY, Estrella JS, Correa A, Pizzi MP, Ma L, Jin J, Liu B, Wang Y, Xiao L, Hofstetter WL, Lee JH, Weston B, Bhutani M, Shanbhag N, Johnson RL, Gan B, Wei S, Ajani JA. Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma. Gut 70(12):2238-2248, 2021. e-Pub 2021. PMID: 33487592.
Corsini EM, Foo WC, Mitchell KG, Zhou N, Maru DM, Ajani JA, Hofstetter WL, Working Group EA, Correa AM, Antonoff MB, Lin SH, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL. Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy. J Thorac Cardiovasc Surg 162(5):1404-1412.e2, 2021. e-Pub 2020. PMID: 33010880.
Pataer A, Weissferdt A, Vaporciyan AA, Correa AM, Sepesi B, Wistuba II, Heymach JV, Cascone T, Swisher SG. Evaluation of Pathologic Response in Lymph Nodes of Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy. J Thorac Oncol 16(8):1289-1297, 2021. e-Pub 2021. PMID: 33857666.
Corsini EM, Mitchell KG, Correa A, Morris VK, Antonoff MB, Group MD. Effect of primary colorectal cancer tumor location on survival after pulmonary metastasectomy. J Thorac Cardiovasc Surg 162(1):296-305, 2021. e-Pub 2020. PMID: 32713636.
Gaudreau PO, Negrao MV, Mitchell KG, Reuben A, Corsini EM, Li J, Karpinets TV, Wang Q, Diao L, Wang J, Federico L, Parra-Cuentas ER, Khairullah R, Behrens C, Correa AM, Gomez D, Little L, Gumbs C, Kadara HN, Fujimoto J, McGrail DJ, Vaporciyan AA, Swisher SG, Walsh G, Antonoff MB, Weissferdt A, Tran H, Roarty E, Haymaker C, Bernatchez C, Zhang J, Futreal PA, Wistuba II, Cascone T, Heymach JV, Sepesi B, Zhang J, Gibbons DL. Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLC. J Thorac Oncol 16(1):127-139, 2021. e-Pub 2021. PMID: 33096269.
Shewale JB, Corsini EM, Correa AM, Brown EL, Leon-Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth J, Walsh GL, Vaporciyan AA, Swisher SG, Sepesi B. Time trends and predictors of survival in surgically resected early-stage non-small cell lung cancer patients. J Surg Oncol 122(3):495-505, 2020. e-Pub 2020. PMID: 32356321.
Rajaram R, Correa AM, Xu T, Nguyen QN, Antonoff MB, Rice D, Mehran R, Roth J, Walsh G, Swisher S, Hofstetter WL, Vaporciyan A, Cascone T, Tsao AS, Papadimitrakopoulou VA, Gandhi S, Liao Z, Sepesi B. Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients. Clin Lung Cancer 21(4):e294-e301, 2020. e-Pub 2020. PMID: 32089476.
Weissferdt A, Pataer A, Vaporciyan AA, Correa AM, Sepesi B, Moran CA, Wistuba II, Roth JA, Shewale JB, Heymach JV, Kalhor N, Cascone T, Hofstetter WL, Lee JJ, Swisher SG. Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy. Clin Lung Cancer 21(4):341-348, 2020. e-Pub 2020. PMID: 32279936.
Corsini EM, Wang J, Wu CC, Fujimoto J, Negrao MV, Chen R, Quek K, Mitchell KG, Chow CB, Little L, Gumbs C, Song X, Behrens C, Correa AM, Antonoff MB, Swisher SG, Heymach JV, Zhang J, Wistuba II, Futreal PA, Sepesi B, Zhang J. Genomic assessment distinguishes intrapulmonary metastases from synchronous primary lung cancers. J Thorac Dis 12(5):1952-1959, 2020. e-Pub 2020. PMID: 32642098.
Moran CA, Lindholm KE, Brunnström H, Langman G, Jang SJ, Spagnolo D, Chai SM, Laycock A, Falconieri G, Pizzolitto S, de Pellegrin A, Medeiros F, Edmunds L, Catarino A, Cunha F, Ro J, Pina-Oviedo S, Torrealba J, Coppola D, Petersson F, Oon ML, Elmberger G, Y Cajal SR, Valero IS, Dalurzo L, Soares F, Campos AH, Vranic S, Skenderi F, Correa AM, Sepesi B, Rice D, Mehran R, Walsh G. Typical and atypical carcinoid tumors of the lung: a clinicopathological correlation of 783 cases with emphasis on histological features. Hum Pathol 98:98-109, 2020. e-Pub 2020. PMID: 32145220.
Van Haren RM, Correa AM, Sepesi B, Rice DC, Hofstetter WL, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Mehran RJ, Antonoff MB. Hospital readmissions after pulmonary resection: post-discharge nursing telephone assessment identifies high risk patients. J Thorac Dis 12(3):184-190, 2020. e-Pub 2020. PMID: 32274083.
Van Haren RM, Rajaram R, Correa AM, Mehran RJ, Antonoff MB, Hofstetter WL, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Roth JA. Preoperative Heparin for Lung Cancer Resection Increases Risk of Reoperation for Bleeding. Semin Thorac Cardiovasc Surg. e-Pub 2019. PMID: 31857153.
Mitchell KG, Nelson DB, Corsini EM, Correa AM, Erasmus JJ, Hofstetter WL, Mehran RJ, Roth JA, Swisher SG, Sepesi B, Walsh GL, Vaporciyan AA, Rice DC, Nguyen QN, Antonoff MB. Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary Standardization. Innovations (Phila):1556984519886281. e-Pub 2019. PMID: 31875755.
Chen Y, Zhang R, Wang L, Correa AM, Pataer A, Xu Y, Zhang X, Ren C, Wu S, Meng QH, Fujimoto J, Jensen VB, Antonoff MB, Hofstetter WL, Mehran RJ, Pisimisis G, Rice DC, Sepesi B, Vaporciyan AA, Walsh GL, Swisher SG, Roth JA, Heymach JV, Fang B. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice. Cancer 125(21):3738-3748, 2019. e-Pub 2019. PMID: 31287557.
Shewale JB, Correa AM, Brown EL, Leon Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Roth J, Vaporciyan AA, Swisher SG, Sepesi B. Time Trends of Perioperative Outcomes in Early-Stage Non-Small Cell Lung Cancer Resection Patients. Ann Thorac Surg. e-Pub 2019. PMID: 31539514.
Semenkovich TR, Subramanian M, Yan Y, Hofstetter WL, Correa AM, Cassivi SD, Inra ML, Stiles BM, Altorki NK, Chang AC, Brescia AA, Darling GE, Allison F, Broderick SR, Etchill EW, Fernandez FG, Chihara RK, Litle VR, Muñoz-Largacha JA, Kozower BD, Puri V, Meyers BF. Adjuvant Therapy for Node-Positive Esophageal Cancer After Induction and Surgery: A Multisite Study. Ann Thorac Surg 108(3):828-836, 2019. e-Pub 2019. PMID: 31229485.
Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Weston BR, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Das P, Blum MA, Badgwell BD, Hofstetter WL. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma. Ann Thorac Surg 108(3):845-851, 2019. e-Pub 2019. PMID: 31102632.
Nelson DB, Mehran RJ, Mitchell KG, Rajaram R, Correa AM, Bassett RL, Antonoff MB, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Walsh GL, Vaporciyan AA, Rice DC. Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience. Ann Thorac Surg 108(2):370-376, 2019. e-Pub 2019. PMID: 31004583.
Nelson DB, Mehran RJ, Mitchell KG, Correa AM, Sepesi B, Antonoff MB, Rice DC. Enhanced recovery after thoracic surgery is associated with improved adjuvant chemotherapy completion for non-small cell lung cancer. J Thorac Cardiovasc Surg 158(1):279-286.e1, 2019. e-Pub 2019. PMID: 31014665.
Nelson DB, Tayob N, Mitchell KG, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Vauthey JN, Mehran RJ. Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases. J Thorac Cardiovasc Surg 157(4):1648-1655, 2019. e-Pub 2019. PMID: 30635188.
Van Haren RM, Correa AM, Sepesi B, Rice DC, Hofstetter WL, Mehran RJ, Vaporciyan AA, Walsh GL, Roth JA, Swisher SG, Antonoff MB. Ground Glass Lesions on Imaging: Evaluation of Reported Incidence Using Natural Language Processing. Ann Thorac Surg 107(3):936-940, 2019. e-Pub 2019. PMID: 30612991.
Tong Z, Mejia A, Veeranki O, Verma A, Correa AM, Dokey R, Patel V, Solis LM, Mino B, Kathkuda R, Rodriguez-Canales J, Lin SH, Krishnan S, Kopetz S, Blum M, Ajani JA, Hofstetter WL, Maru DM. Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma. Ther Adv Med Oncol 11:1758835919864850, 2019. e-Pub 2019. PMID: 31384313.
Baity M, Wang L, Correa AM, Zhang X, Zhang R, Pataer A, Wu S, Meng QH, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Zhao M, Gu J, Fang B. Glutathione reductase (GSR) gene deletion and chromosome 8 aneuploidy in primary lung cancers detected by fluorescence in situ hybridization. Am J Cancer Res 9(6):1201-1211, 2019. e-Pub 2019. PMID: 31285952.
Kim MP, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Erasmus JJ, Swisher SG. Occult stage IIIA-N2 patients have excellent overall survival with initial surgery. J Thorac Dis 10(12):6670-6676, 2018. e-Pub 2018. PMID: 30746212.
Nelson DB, Lapid DJ, Mitchell KG, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff MB. Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences between Men and Women. Ann Thorac Surg 106(5):1499-1503, 2018. e-Pub 2018. PMID: 30118712.
Sanchez N, Shewale JB, Baker CM, Wilks SA, Correa AM, Sepesi B, Rice DC, Roth JA, Walsh GL, Swisher SG, Vaporciyan AA, Mehran RJ, Hofstetter WL. Early Foley catheter removal in thoracic surgical oncology patients receiving epidural analgesia. Perioperative Care and Operating Room Management 12:1-5, 2018. e-Pub 2018.
Palacio D, Marom EM, Correa A, Betancourt-Cuellar SL, Hofstetter WL. Diagnosing conduit leak after esophagectomy for esophageal cancer by computed tomography leak protocol and standard esophagram: Is old school still the best?. Clin Imaging 51:23-29, 2018. e-Pub 2018. PMID: 29414520.
Nelson DB, Dhupar R, Katkhuda R, Correa A, Goltsov A, Maru D, Sepesi B, Antonoff MB, Mehran RJ, Rice DC, Vaporciyan AA, Davila M, Davila R, Betancourt S, Ajani J, Hofstetter WL. Outcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinoma. J Thorac Cardiovasc Surg 156(1):406-413.e3, 2018. e-Pub 2018. PMID: 29605441.
Van Haren RM, Mehran RJ, Mena GE, Correa AM, Antonoff MB, Baker CM, Woodard TC, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. Enhanced Recovery Decreases Pulmonary and Cardiac Complications After Thoracotomy for Lung Cancer. Ann Thorac Surg 106(1):272-279, 2018. e-Pub 2018. PMID: 29530770.
Zabaleta J, Iida T, Falcoz PE, Salah S, Jarabo JR, Correa AM, Zampino MG, Matsui T, Cho S, Ardissone F, Watanabe K, Gonzalez M, Gervaz P, Emparanza JI, Abraira V. Individual data meta-analysis for the study of survival after pulmonary metastasectomy in colorectal cancer patients: A history of resected liver metastases worsens the prognosis. Eur J Surg Oncol 44(7):1006-1012, 2018. e-Pub 2018. PMID: 29602524.
Pataer A, Shao R, Correa AM, Behrens C, Roth JA, Vaporciyan AA, Wistuba II, Swisher SG. Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy. Cancer Med 7(6):2405-2414, 2018. e-Pub 2018. PMID: 29673125.
Weissferdt A, Kalhor N, Bishop JA, Jang SJ, Ro J, Petersson F, Wu B, Langman G, Bancroft H, Bi Y, Meng Y, Medeiros F, Brunnstrom H, Spagnolo D, Chai SM, Laycock A, Wakely PE, Elmberger G, Soares FA, Campos AH, Gumurdulu D, Alvarado-Cabrero I, Coppola D, Correa AM, Rice D, Mehran RJ, Sepesi B, Walsh G, Kaiser L, Moran CA. THYMOMA: A clinicopathological correlation of 1470 cases. Hum Pathol 73:7-15, 2018. e-Pub 2018. PMID: 28851660.
Betancourt Cuellar SL, Palacio DP, Wu CC, Carter BW, Correa AM, Hofstetter WL, Marom EM. 18FDG-PET/CT is useful in the follow-up of surgically treated patients with oesophageal adenocarcinoma. Br J Radiol 91(1082):20170341, 2018. e-Pub 2018. PMID: 29125331.
Harada K, Dong X, Estrella JS, Correa AM, Xu Y, Hofstetter WL, Sudo K, Onodera H, Suzuki K, Suzuki A, Johnson RL, Wang Z, Song S, Ajani JA. Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma. Gastric Cancer 21(1):31-40, 2018. e-Pub 2018. PMID: 28801853.
Ajani JA, Estrella JS, Chen Q, Correa AM, Ma L, Scott AW, Jin J, Liu B, Xie M, Sudo K, Shiozaki H, Badgwell B, Weston B, Lee JH, Bhutani MS, Onodera H, Suzuki K, Suzuki A, Ding S, Hofstetter WL, Johnson RL, Bresalier RS, Song S. Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors. Br J Cancer 118(1):52-61, 2018. e-Pub 2018. PMID: 29136404.
Ontiveros N, Eapen-John D, Osorio N, Song J, Li L, Sheshadri A, Tiang X, Ghosh N, Vaporciyan A, Correa A, Walsh G, Grosu HB, Ost DE. Predicting Lung Function Following Lobectomy: A New Method to Adjust for Inherent Selection Bias. Respiration 96(5):434-445, 2018. e-Pub 2018. PMID: 30257257.
Atay SM, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh G, Antonoff MB. Perioperative Outcomes of Patients Undergoing Lobectomy on Clopidogrel. Ann Thorac Surg 104(6):1821-1828, 2017. e-Pub 2017. PMID: 28987393.
Pence K, Correa AM, Chan E, Khaitan P, Hofstetter W, Kim MP. Management of esophageal gastrointestinal stromal tumor: review of one hundred seven patients. Dis Esophagus 30(12):1-5, 2017. e-Pub 2017. PMID: 28881878.
Blum Murphy M, Xiao L, Patel VR, Maru DM, Correa AM, G Amlashi F, Liao Z, Komaki R, Lin SH, Skinner HD, Vaporciyan A, Walsh GL, Swisher SG, Sepesi B, Lee JH, Bhutani MS, Weston B, Hofstetter WL, Ajani JA. Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience. Cancer 123(21):4106-4113, 2017. e-Pub 2017. PMID: 28885712.
Sepesi B, Correa AM, Dmitrovsky E, Liu X. Reply to "Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non-Small Cell Lung Cancer: Methodological Issues". J Thorac Oncol 12(9):e150-e151, 2017. e-Pub 2017. PMID: 28838719.
Antonoff MB, Correa AM, Sepesi B, Nguyen QN, Walsh GL, Swisher SG, Vaporciyan AA, Mehran RJ, Hofstetter WL, Rice DC. Salvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients. J Thorac Cardiovasc Surg 154(2):689-699, 2017. e-Pub 2017. PMID: 28495066.
Sepesi B, Gold KA, Correa AM, Heymach JV, Vaporciyan AA, Roszik J, Dmitrovsky E, Liu X. The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non-Small Cell Lung Cancer. J Thorac Oncol 12(8):1280-1287, 2017. e-Pub 2017. PMID: 28552766.
Bassuner JK, Rice DC, Antonoff MB, Correa AM, Walsh GL, Vaporciyan AA, Garg N, Sepesi B, Swisher SG, Hofstetter WL, Roth JA, Mehran RJ. Polytetrafluoroethylene or Acellular Dermal Matrix for Diaphragmatic Reconstruction?. Ann Thorac Surg 103(6):1710-1714, 2017. e-Pub 2017. PMID: 28366460.
Lin SH, Merrell KW, Shen J, Verma V, Correa AM, Wang L, Thall PF, Bhooshan N, James SE, Haddock MG, Suntharalingam M, Mehta MP, Liao Z, Cox JD, Komaki R, Mehran RJ, Chuong MD, Hallemeier CL. Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer. Radiother Oncol 123(3):376-381, 2017. e-Pub 2017. PMID: 28455153.
Weissferdt A, Kalhor N, Correa AM, Moran CA. "Sarcomatoid" carcinomas of the lung: a clinicopathologic study of 86 cases with a new perspective on tumor classification. Hum Pathol 63:14-26, 2017. e-Pub 2017. PMID: 27993578.
Sepesi B, Cuentes EP, Canales JR, Behrens C, Correa A, Antonoff M, Gibbons DL, Heymach J, Hofstetter W, Mehran R, Rice DC, Roth J, Vaporciyan AA, Walsh G, Weissferdt A, Kalhor N, Moran C, Swisher SG, Wistuba I. Tumor-Infiltrating Lymphocytes and Overall Survival in Surgically Resected Stage II and III Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 98(1):223, 2017. e-Pub 2017. PMID: 28586974.
Betancourt Cuellar SL, Sabloff B, Carter BW, Benveniste MF, Correa AM, Maru DM, Ajani JA, Erasmus JJ, Hofstetter WL. Early clinical esophageal adenocarcinoma (cT1): Utility of CT in regional nodal metastasis detection and can the clinical accuracy be improved?. Eur J Radiol 88:56-60, 2017. e-Pub 2017. PMID: 28189209.
Lopez C, Correa A, Vaporciyan A, Austin M, Rice D, Hayes-Jordan A. Outcomes of chest wall resections in pediatric sarcoma patients. J Pediatr Surg 52(1):109-114, 2017. e-Pub 2017. PMID: 27914587.
Mehran RJ, Walsh GL, Zalpour A, Cata JP, Correa AM, Antonoff MB, Rice DC. Intercostal Nerve Blocks With Liposomal Bupivacaine: Demonstration of Safety, and Potential Benefits. Semin Thorac Cardiovasc Surg 29(4):531-537, 2017. e-Pub 2017. PMID: 29698654.
Sepesi B, Cuentas EP, Canales JR, Behrens C, Correa AM, Vaporciyan A, Weissferdt A, Kalhor N, Moran C, Swisher S, Wistuba I. Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer. Semin Thorac Cardiovasc Surg 29(3):408-415, 2017. e-Pub 2017. PMID: 29195578.
Spicer JD, Shewale JB, Antonoff MB, AM| C, Hofstetter WB, Rice DC, Vaporciyan AA, Mehran RJ, Walsh GL, Roth JA, Swisher SG, Sepesi B. The Influence of Reconstructive Technique on Perioperative Pulmonary and Infectious Outcomes Following Chest Wall Resection. Ann Thorac Surg 102(16):30567-7, 2016. e-Pub 2016. PMID: 27526650.
Rice TW, Ishwaran H, Blackstone EH, Hofstetter WL, Kelsen DP, Apperson-Hansen C, Collaboration Investigators WEC. Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus 29(8):913-919, 2016. e-Pub 2016. PMID: 27905171.
Rice TW, Ishwaran H, Kelsen DP, Hofstetter WL, Apperson-Hansen C, Blackstone EH, Collaboration Investigators WEC. Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus 29(8):906-912, 2016. e-Pub 2016. PMID: 27905170.
Liu Y, Zhang J, Li L, Yin G, Zhang J, Zheng S, Cheung H, Wu N, Lu N, Mao X, Yang L, Zhang J, Zhang L, Seth S, Chen H, Song X, Liu K, Xie Y, Zhou L, Zhao C, Han N, Chen W, Zhang S, Chen L, Cai W, Li L, Shen M, Xu N, Cheng S, Yang H, Lee JJ, Correa A, Fujimoto J, Behrens C, Chow CW, William WN, Heymach JV, Hong WK, Swisher S, Wistuba II, Wang J, Lin D, Liu X, Futreal PA, Gao Y. Genomic heterogeneity of multiple synchronous lung cancer. Nat Commun 7:13200, 2016. e-Pub 2016. PMID: 27767028.
Antonoff MB, Ragalie W, AM C, Spicer JD, Sepesi B, Roth JA, Walsh GL, Hofstetter WL, Swisher SG, Rice DC, Vaporciyan AA, Mehran RJ. Results of Postdischarge Nursing Telephone Assessments: Persistent Symptoms Common Among Pulmonary Resection Patients. Ann Thorac Surg 102(1):276-81, 2016. e-Pub 2016. PMID: 27083250.
Spicer JD, Stiles BM, Sudarshan M, Correa AM, Ferri LE, Altorki NK, Hofstetter WL. Preoperative Chemoradiation Therapy Versus Chemotherapy in Patients Undergoing Modified En Bloc Esophagectomy for Locally Advanced Esophageal Adenocarcinoma: Is Radiotherapy Beneficial?. Ann Thorac Surg 101(4):1262-1270, 2016. e-Pub 2016. PMID: 26916717.
Sepesi B, Schmidt HE, Lada M, Correa AM, Walsh GL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Watson TJ, Swisher SG, Low DE, Hofstetter WL. Survival in Patients with Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location. Ann Thorac Surg 101(3):1075-80, 2016. e-Pub 2016. PMID: 26680311.
Antonoff MB, Hofstetter WL, Correa AM, Bell JM, Sepesi B, Rice DC, Vaporciyan AA, Walsh GL, Mehran RJ, Swisher SG, Meyers BF. Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small Cell Lung Cancer. Ann Thorac Surg 101(1):211-7, 2016. e-Pub 2016. PMID: 26279367.
Dhupar R, Rice RD, Correa AM, Weston BR, Bhutani MS, Maru DM, Betancourt SL, Rice DC, Swisher SG, Hofstetter WL. Endoscopic Ultrasound Estimates for Tumor Depth at the Gastroesophageal Junction Are Inaccurate: Implications for the Liberal Use of Endoscopic Resection. Ann Thorac Surg 100(5):1812-6, 2015. e-Pub 2015. PMID: 26233274.
Stephens EH, Gaur P, Hotze KO, Correa AM, Kim MP, Blackmon SH. Super-Charged Pedicled Jejunal Interposition Performance Compares Favorably With a Gastric Conduit After Esophagectomy. Ann Thorac Surg 100(2):407-13, 2015. e-Pub 2015. PMID: 26101096.
Hildebrandt MA, Roth JA, Vaporciyan AA, Pu X, Ye Y, Correa AM, Kim JY, Swisher SG, Wu X. Genetic variation in the TNF/TRAF2/ASK1/p38 kinase signaling pathway as markers for postoperative pulmonary complications in lung cancer patients. Sci Rep 5:12068, 2015. e-Pub 2015. PMID: 26165383.
Rice DC, Cata JP, Mena GE, Rodriguez-Restrepo A, Correa AM, Mehran RJ. Posterior Intercostal Nerve Block With Liposomal Bupivacaine: An Alternative to Thoracic Epidural Analgesia. Ann Thorac Surg 99(6):1953-60, 2015. e-Pub 2015. PMID: 25912739.
Song S, Honjo S, Jin J, Chang SS, Scott AW, Chen Q, Kalhor N, Correa AM, Hofstetter WL, Albarracin CT, Wu TT, Johnson RL, Hung MC, Ajani JA. The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer. Clin Cancer Res 21(11):2580-90, 2015. e-Pub 2015. PMID: 25739674.
Shewale JB, Correa AM, Baker CM, Villafane-Ferriol N, Hofstetter WL, Jordan VS, Kehlet H, Lewis KM, Mehran RJ, Summers BL, Schaub D, Wilks SA, Swisher SG, Collaborative Group UOTMAEC. Impact of a Fast-Track Esophagectomy Protocol on Esophageal Cancer Patient Outcomes and Hospital Charges. Ann Surg 261(6):1114-23, 2015. e-Pub 2015. PMID: 25243545.
Guo C, Hao C, Shao R, Fang B, Correa AM, Hofstetter WL, Roth JA, Behrens C, Kalhor N, Wistuba II, Swisher SG, Pataer A. RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer. Oncotarget 6(13):11114-24, 2015. e-Pub 2015. PMID: 25798539.
Kim MP, Correa AM, Hofstetter W, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Erasmus JJ, Swisher SG. Limitations of 18F-2-deoxy-D-glucose positron emission tomography in N1 detection in patients with pathologic stage II-N1 and implications for management. Ann Thorac Surg 99(2):414-20, 2015. e-Pub 2015. PMID: 25497068.
Lin SH, Wang J, Allen PK, Correa AM, Maru DM, Swisher SG, Hofstetter WL, Liao Z, Ajani JA. A nomogram that predicts pathologic complete response to neoadjuvant chemoradiation also predicts survival outcomes after definitive chemoradiation for esophageal cancer. J Gastrointest Oncol 6(1):45-52, 2015. e-Pub 2015. PMID: 25642337.
Dhupar R, Correa AM, Ajani J, Betancourt S, Mehran RJ, Swisher SG, Hofstetter WL. Concordance of studies for nodal staging is prognostic for worse survival in esophageal cancer. Dis Esophagus 27(8):770-6, 2014. e-Pub 2014. PMID: 24152134.
Stephens N, Rice D, Correa A, Hoffstetter W, Mehran R, Roth J, Walsh G, Vaporciyan A, Swisher S. Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical Stage I non-small-cell lung cancer: a propensity-matched analysis of 963 cases. Eur J Cardiothorac Surg 46(4):607-13, 2014. e-Pub 2014. PMID: 24603446.
Pham DT, Stephens EH, Antonoff MB, Colson YL, Dildy GA, Gaur P, Correa AM, Litle VR, Blackmon SH. Birth trends and factors affecting childbearing among thoracic surgeons. Ann Thorac Surg 98(3):890-5, 2014. e-Pub 2014. PMID: 25087932.
Patel VR, Hofstetter WL, Correa AM, Agarwal A, Rashid A, Bhutani MS, Lin SH, Ajani JA, Swisher SG, Maru DM. Signet ring cells in esophageal adenocarcinoma predict poor response to preoperative chemoradiation. Ann Thorac Surg 98(3):1064-71, 2014. e-Pub 2014. PMID: 25038008.
Subbiah IM, Blackmon SH, Correa AM, Kee B, Vaporciyan AA, Swisher SG, Eng C. Preoperative chemotherapy prior to pulmonary metastasectomy in surgically resected primary colorectal carcinoma. Oncotarget 5(16):6584-93, 2014. e-Pub 2014. PMID: 25051371.
Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, Lee JH, Swisher SG, Correa AM, Erasmus JJ, Hofstetter WL. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?. J Thorac Oncol 9(8):1202-6, 2014. e-Pub 2014. PMID: 25157774.
Taketa T, Sudo K, Correa AM, Wadhwa R, Shiozaki H, Elimova E, Campagna MC, Blum MA, Skinner HD, Komaki RU, Lee JH, Bhutani MS, Weston BR, Rice DC, Swisher SG, Maru DM, Hofstetter WL, Ajani JA. Post-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinoma. J Natl Compr Canc Netw 12(8):1139-44, 2014. e-Pub 2014. PMID: 25099446.
Stephens EH, Correa AM, Kim MP, Gaur P, Blackmon SH. Classification of esophageal stent leaks: leak presentation, complications, and management. Ann Thorac Surg 98(1):297-303; discussion 303-4, 2014. e-Pub 2014. PMID: 24835152.
Juloori A, Tucker SL, Komaki R, Liao Z, Correa AM, Swisher SG, Hofstetter WL, Lin SH. Influence of preoperative radiation field on postoperative leak rates in esophageal cancer patients after trimodality therapy. J Thorac Oncol 9(4):534-40, 2014. e-Pub 2014. PMID: 24736077.
Sudo K, Taketa T, Correa AM, Campagna MC, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, Skinner HD, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Locoregional Failure Rate After Preoperative Chemoradiation of Esophageal Adenocarcinoma and the Outcomes of Salvage Strategies. J Clin Oncol 31(34):4306-10, 2013. e-Pub 2013. PMID: 24145339.
Ertan A, Zaheer I, Correa AM, Thosani N, Blackmon SH. Photodynamic therapy vs radiofrequency ablation for Barrett's dysplasia: Efficacy, safety and cost-comparison. World J Gastroenterol 19(41):7106-13, 2013. e-Pub 2013. PMID: 24222954.
Ganeshan DM, Correa AM, Bhosale P, Vaporciyan AA, Rice D, Mehran RJ, Walsh GL, Iyer R, Roth JA, Swisher SG, Hofstetter WL. Diaphragmatic hernia after esophagectomy in 440 patients with long-term follow-up. Ann Thorac Surg 96(4):1138-45, 2013. e-Pub 2013. PMID: 23810174.
Murphy CC, Hofstetter WL, Correa AM, Ajani JA, Komaki RU, Swisher SG. Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting. Dis Esophagus 26(7):708-715, 2013. e-Pub 2013. PMID: 23350713.
Wadhwa R, Taketa T, Correa AM, Sudo K, Campagna MC, Blum MA, Komaki R, Skinner H, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Incidence of Brain Metastases after Trimodality Therapy in Patients with Esophageal or Gastroesophageal Cancer: Implications for Screening and Surveillance. Oncology 85(4):204-207. e-Pub 2013. PMID: 24051869.
Francis AM, Sepesi B, Correa AM, Blum MA, Erasmus JJ, Lee JH, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Welsh JW, Swisher SG, Hofstetter WL, Cancer Group UOTMAE. The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma. Ann Surg 258(3):500-7, 2013. e-Pub 2013. PMID: 24022442.
Murphy CC, Incalcaterra JR, Albright HW, Correa AM, Swisher SG, Hofstetter WL. Pretreatment patient comorbidity and tobacco use increase cost and risk of postoperative complications after esophagectomy at a high-volume cancer center. J Oncol Pract 9(5):233-9, 2013. e-Pub 2013. PMID: 23943906.
Ganeshan DM, Bhosale P, Munden RF, Hofstetter WL, Correa AM, Iyer R. Diaphragmatic Hernia After Esophagectomy for Esophageal Malignancy. J Thorac Imaging 28(5):308-14, 2013. e-Pub 2013. PMID: 23222201.
Murphy CC, Correa AM, Ajani JA, Komaki RU, Welsh JW, Swisher SG, Hofstetter WL. Surgery is an essential component of multimodality therapy for patients with locally advanced esophageal adenocarcinoma. J Gastrointest Surg 17(8):1359-69, 2013. e-Pub 2013. PMID: 23715646.
Weissferdt A, Kalhor N, Marom EM, Benveniste MF, Godoy MC, Correa AM, Swisher SG, Moran CA. Early-stage pulmonary adenocarcinoma (T1N0M0): a clinical, radiological, surgical, and pathological correlation of 104 cases. The MD Anderson Cancer Center Experience. Mod Pathol 26(8):1065-75, 2013. e-Pub 2013. PMID: 23542459.
Amini A, Lou F, Correa AM, Baldassarre R, Rimner A, Huang J, Roth JA, Swisher SG, Vaporciyan AA, Lin SH. Predictors for Locoregional Recurrence for Clinical Stage III-N2 Non-small Cell Lung Cancer with Nodal Downstaging After Induction Chemotherapy and Surgery. Ann Surg Oncol 20(6):1934-40, 2013. e-Pub 2013. PMID: 23263700.
Song S, Maru DM, Ajani JA, Chan CH, Honjo S, Lin HK, Correa A, Hofstetter WL, Davila M, Stroehlein J, Mishra L. Loss of TGF-β adaptor β2SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma. Cancer Res 73(7):2159-69, 2013. e-Pub 2013. PMID: 23536563.
Guo C, Shao R, Correa AM, Behrens C, Johnson FM, Raso MG, Prudkin L, Solis LM, Nunez MI, Fang B, Roth JA, Wistuba II, Swisher SG, Lin T, Pataer A. Prognostic significance of combinations of RNA-dependent protein kinase and EphA2 biomarkers for NSCLC. J Thorac Oncol 8(3):301-8, 2013. e-Pub 2013. PMID: 23370317.
William WN, Pataer A, Kalhor N, Correa AM, Rice DC, Wistuba II, Heymach J, Lee JJ, Kim ES, Munden R, Gold KA, Papadimitrakopoulou V, Swisher SG, Erasmus JJ, Research Group UOTMALCC. Computed Tomography RECIST Assessment of Histopathologic Response and Prediction of Survival in Patients with Resectable Non-Small-Cell Lung Cancer after Neoadjuvant Chemotherapy. J Thorac Oncol 8(2):222-8, 2013. e-Pub 2013. PMID: 23287849.
Schier R, Hinkelbein J, Marcus H, Smallwood A, Correa AM, Mehran R, El-Zein R, Riedel B. A novel technique for the assessment of preoperative cardiovascular risk: reactive hyperemic response to short-term exercise. Biomed Res Int 2013:837130, 2013. e-Pub 2013. PMID: 23691513.
Blackmon SH, Stephens EH, Correa AM, Hofstetter W, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA. Predictors of recurrent pulmonary metastases and survival after pulmonary metastasectomy for colorectal cancer. Ann Thorac Surg 94(6):1802-9, 2012. e-Pub 2012. PMID: 23063195.
Sepesi B, Swisher SG, Walsh GL, Correa A, Mehran RJ, Rice D, Roth J, Vaporciyan A, Hofstetter WL. Omental reinforcement of the thoracic esophagogastric anastomosis: an analysis of leak and reintervention rates in patients undergoing planned and salvage esophagectomy. J Thorac Cardiovasc Surg 144(5):1146-50, 2012. e-Pub 2012. PMID: 22939861.
Ajani JA, Correa AM, Hofstetter WL, Rice DC, Blum MA, Suzuki A, Taketa T, Welsh J, Lin SH, Lee JH, Bhutani MS, Ross WA, Maru DM, Macapinlac HA, Erasmus J, Komaki R, Mehran RJ, Vaporciyan AA, Swisher SG. Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 23(10):2638-42, 2012. e-Pub 2012. PMID: 22831985.
Blackmon SH, Correa AM, Skoracki R, Chevray PM, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Yu P, Walsh GL, Hofstetter WL. Supercharged pedicled jejunal interposition for esophageal replacement: a 10-year experience. Ann Thorac Surg 94(4):1104-11; discussion 1111-3, 2012. e-Pub 2012. PMID: 22939245.
Marks JL, Hofstetter W, Correa AM, Mehran RJ, Rice D, Roth J, Walsh G, Vaporciyan A, Erasmus J, Chang J, Maru D, Lee JH, Lee J, Ajani JA, Swisher SG. Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma. Ann Thorac Surg 94(4):1126-32; discussion 1132-3, 2012. e-Pub 2012. PMID: 22921233.
Kim JY, Hildebrandt MA, Pu X, Ye Y, Correa AM, Vaporciyan AA, Wu X, Roth JA. Variations in the vascular endothelial growth factor pathway predict pulmonary complications. Ann Thorac Surg 94(4):1079-84; discussion 1084-5, 2012. e-Pub 2012. PMID: 22795057.
Swisher S, Ajani J, Correa A, Komaki R, Hofstetter W. Minimally invasive versus open oesophagectomy for oesophageal cancer. Lancet 380(9845):883; author reply 885-6, 2012. e-Pub 2012. PMID: 22959377.
Amini A, Correa AM, Komaki R, Chang JY, Tsao AS, Roth JA, Swisher SG, Rice DC, Vaporciyan AA, Lin SH. The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy. Ann Thorac Surg 94(3):914-20, 2012. e-Pub 2012. PMID: 22819472.
Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Mehran RJ, Rice DC, Suzuki A, Lee JH, Bhutani MS, Welsh J, Lin SH, Maru DM, Swisher SG, Ajani JA. Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis. Dis Esophagus 25(7):614-22, 2012. e-Pub 2012. PMID: 22150920.
Pataer A, Kalhor N, Correa AM, Raso MG, Erasmus JJ, Kim ES, Behrens C, Lee JJ, Roth JA, Stewart DJ, Vaporciyan AA, Wistuba II, Swisher SG, Research Group UOTMDALCC. Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy. J Thorac Oncol 7(5):825-32, 2012. e-Pub 2012. PMID: 22481232.
Harvin JA, Lahat G, Correa AM, Lee J, Maru D, Ajani J, Marom EM, Welsh J, Bhutani MS, Walsh G, Roth J, Mehran R, Vaporciyan A, Rice D, Swisher S, Hofstetter W. Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: Significance of microscopically positive circumferential radial margins. J Thorac Cardiovasc Surg 143(2):412-20, 2012. e-Pub 2012. PMID: 22172216.
Kim JY, Correa AM, Vaporciyan AA, Roth JA, Mehran RJ, Walsh GL, Rice DC, Ajani JA, Maru DM, Bhutani MS, Welsh J, Marom EM, Swisher SG, Hofstetter WL. Does the Timing of Esophagectomy After Chemoradiation Affect Outcome?. Ann Thorac Surg 93(1):207-13, 2012. e-Pub 2012. PMID: 21962263.
He Y, Zhou Z, Hofstetter WL, Zhou Y, Hu W, Guo C, Wang L, Guo W, Pataer A, Correa AM, Lu Y, Wang J, Diao L, Byers LA, Wistuba II, Roth JA, Swisher SG, Heymach JV, Fang B. Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parameters. PLoS One 7(2):e31087, 2012. e-Pub 2012. PMID: 22348039.
Taketa T, Correa AM, Suzuki A, Blum MA, Chien P, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Vaporciyan AA, Hofstetter WL, Swisher SG, Ajani JA. Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation. Oncology 83(5):300-4, 2012. e-Pub 2012. PMID: 22964903.
Hemmati SH, Correa AM, Walsh GL, Swisher SG, Roth JA, Rice DC, Mehran RJ, Vaporciyan AA. The prognostic factors of chest wall metastasis resection. Eur J Cardiothorac Surg 40(2):328-33, 2011. e-Pub 2011. PMID: 21466960.
Estrella JS, Hofstetter WL, AM C, Swisher SG, Ajani JA, Lee JH, Bhutani MS, Abraham SC, Rashid A, Maru DM. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma. Am J Surg Pathol 35(7):1045-53, 2011. e-Pub 2011. PMID: 21602659.
Marom EM, Milito MA, Moran CA, Liu P, AM C, Kim ES, Komaki R, Erasmus JJ, Hofstetter WL, Rice DC, Swisher SG. Computed tomography findings predicting invasiveness of thymoma. J Thorac Oncol 6(7):1274-81, 2011. e-Pub 2011. PMID: 21623235.
Stephens EH, Blackmon SH, AM C, Roth JA, Rice DC, Hofstetter W, Benjamin R, Mehran R, Swisher SG, Walsh GL, Vaporciyan AA. Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients. J Am Coll Surg 212(5):821-6, 2011. e-Pub 2011. PMID: 21435923.
Mehran R, Rice D, El-Zein R, Huang JL, Vaporciyan A, Goodyear A, Mehta A, Correa A, Walsh G, Roth J, Swisher S, Hofstetter W. Minimally invasive esophagectomy versus open esophagectomy, a symptom assessment study. Dis Esophagus 24(3):147-52, 2011. e-Pub 2011. PMID: 21040152.
Kountourakis P, Correa AM, Hofstetter WL, Lee JH, Bhutani MS, Rice DC, Komaki R, Maru DM, Ross WA, Vaporciyan A, Swisher SG, Ajani JA. Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience. Cancer 117(5):925-30, 2011. e-Pub 2011. PMID: 20960497.
Kim MP, AM C, Blackmon S, Quiroga-Garza G, Weilbaecher D, Bruckner B, Ramlawi B, Rice DC, Vaporciyan AA, Reardon MJ. Outcomes after right-side heart sarcoma resection. Ann Thorac Surg 91(3):770-6, 2011. e-Pub 2011. PMID: 21352995.
Hu Y, AM C, Hoque A, Guan B, Ye F, Huang J, Swisher SG, Wu TT, Ajani JA, Xu XC. Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int J Cancer 128(1):132-43, 2011. e-Pub 2011. PMID: 20309880.
Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Watson TJ, Swisher SG, Group M, of Medicine UORS, Group DF. Endoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer. Cancer 117(1):63-9, 2011. e-Pub 2011. PMID: 20803613.
He Y, AM C, Raso MG, Hofstetter WL, Fang B, Behrens C, Roth JA, Zhou Y, Yu L, Wistuba II, Swisher SG, Pataer A. The Role of PKR/eIF2a Signaling Pathway in Prognosis of Non-Small Cell Lung Cancer. PLoS One 6(11):e24855, 2011. e-Pub 2011. PMID: 22102852.
Yokoyama T, Tam J, Kuroda S, Scott AW, Aaron J, Larson T, Shanker M, AM C, Kondo S, Roth JA, Sokolov K, Ramesh R. EGFR-Targeted Hybrid Plasmonic Magnetic Nanoparticles Synergistically Induce Autophagy and Apoptosis in Non-Small Cell Lung Cancer Cells. PLoS One 6(11):e25507, 2011. e-Pub 2011. PMID: 22087216.
Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Lee JH, Bhutani MS, Dekovich A, Swisher SG, Ajani JA. The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy. Cancer 116(24):5619-27, 2010. e-Pub 2010. PMID: 21136578.
Pataer A, Raso MG, Correa AM Behrens C, Tsuta K, Solis L, Fang B, Roth JA, Wistuba II, Swisher SG. Prognostic significance of RNA-dependent protein kinase on non-small cell lung cancer patients. Clin Cancer Res 16(22):5522-8, 2010. e-Pub 2010. PMID: 20930042.
Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Vaporciyan AA, Watson TJ, Swisher SG, Cancer Group MOTMAE, of Medicine TUORS, Group DF. A clinical nomogram predicting pathologic lymph node involvement in esophageal cancer patients. Ann Surg 252(4):611-7, 2010. e-Pub 2010. PMID: 20881767.
Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Lee JH, Liao Z, Maru D, Mehran R, Patel S, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani JA. Improved Long-Term Outcome With Chemoradiotherapy Strategies in Esophageal Cancer. Ann Thorac Surg 90(3):892-899, 2010. e-Pub 2010. PMID: 20732514.
Kim MP, Correa AM, Lee J, Rice DC, Roth JA, Mehran RJ, Walsh GL, Ajani JA, Maru DM, Chang JY, Marom EM, Macapinlac HA, Lee JH, Vaporciyan AA, Rice T, Swisher SG, Hofstetter WL. Pathologic T0N1 Esophageal Cancer After Neoadjuvant Therapy and Surgery: An Orphan Status. Ann Thorac Surg 90(3):884-891, 2010. e-Pub 2010. PMID: 20732513.
Kim MP, Correa AM, Swisher SG, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Erasmus J, Moran C, Vaporciyan AA, Roth JA. Non-small cell lung cancer resection in lymphoma patients. Ann Thorac Surg 90(1):210-6, 2010. e-Pub 2010. PMID: 20609777.
Gaur P, Hofstetter WL, Bekele BN, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Rice TW, Swisher SG. Comparison between established and the Worldwide Esophageal Cancer Collaboration staging systems. Ann Thorac Surg 89(6):1797-1803, 1804.e1-3; discussion 1803-4, 2010. e-Pub 2010. PMID: 20494031.
Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SG. Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction. Cancer 116(7):1656-63, 2010. e-Pub 2010. PMID: 20143431.
Goodarzi M, Correa AM, Ajani JA, Swisher SG, Hofstetter WL, Guha S, Deavers MT, Rashid A, Maru DM. Anti-phosphorylated histone H3 expression in Barrett's esophagus, low-grade dysplasia, high-grade dysplasia, and adenocarcinoma. Mod Pathol 22(12):1612-21, 2009. e-Pub 2009. PMID: 19734842.
Wu TT, Levy M, Correa AM, Rosen CB, Abraham SC. Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases. Cancer 115(19):4564-75, 2009. e-Pub 2009. PMID: 19670455.
Braiteh F, Correa AM, Hofstetter WL, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Mehran RJ, Swisher SG, Ajani JA. Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy. Cancer 115(19):4450-8, 2009. e-Pub 2009. PMID: 19562780.
Bolton WD, Hofstetter WL, Francis AM, Correa AM, Ajani JA, Bhutani MS, Erasmus J, Komaki R, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg 138(4):831-6, 2009. e-Pub 2009. PMID: 19660349.
Blackmon SH, Shah N, Roth JA, Correa AM, Vaporciyan AA, Rice DC, Hofstetter W, Walsh GL, Benjamin R, Pollock R, Swisher SG, Mehran R. Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg 88(3):877-84; discussion 884-5, 2009. e-Pub 2009. PMID: 19699915.
Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele BN, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Pisters KM, Rice DC, Walsh GL, Roth JA. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. J Thorac Cardiovasc Surg 138(2):412-418.e1-2, 2009. e-Pub 2009. PMID: 19619787.
Bolton WD, Rice DC, Correa AM, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Influence of age on choice of therapy and surgical outcomes in patients with nonsmall cell lung cancer. Am Surg 75(7):598-603; discussion 603-4, 2009. e-Pub 2009. PMID: 19655604.
Bolton WD, Rice DC, Goodyear A, Correa AM, Erasmus J, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, Rhines L. Superior sulcus tumors with vertebral body involvement: a multimodality approach. J Thorac Cardiovasc Surg 137(6):1379-87, 2009. e-Pub 2009. PMID: 19464452.
Maru DM, Luthra R, Correa AM, White-Cross J, Anandasabapathy S, Krishnan S, Guha S, Komaki R, Swisher SG, Ajani JA, Hofstetter WL, Rashid A. Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survival. Cancer 115(7):1576-85, 2009. e-Pub 2009. PMID: 19156915.
Blackmon SH, Rice DC, Correa AM, Mehran R, Putnam JB, Smythe WR, Walkes JC, Walsh GL, Moran C, Singh H, Vaporciyan AA, Reardon M. Management of primary pulmonary artery sarcomas. Ann Thorac Surg 87(3):977-984, 2009. e-Pub 2009. PMID: 19231448.
Yendamuri S, Swisher SG, Correa AM, Hofstetter W, Ajani JA, Francis A, Maru D, Mehran RJ, Rice DC, Roth JA, Walsh GL, Vaporciyan AA. Esophageal tumor length is independently associated with long-term survival. Cancer 115(3):508-16, 2009. e-Pub 2009. PMID: 19117343.
Cen P, Correa AM, Lee JH, Le JH, Maru D, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA, Vaporciyan A, Ajani JA. Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation. Dis Esophagus 22(1):32-41, 2009. e-Pub 2009. PMID: 19021684.
Maru DM, Khurana H, Rashid A, Correa AM, Anandasabapathy S, Krishnan S, Komaki R, Ajani JA, Swisher SG, Hofstetter WL. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol 32(9):1404-11, 2008. e-Pub 2008. PMID: 18670347.
Javeri H, Arora R, Correa AM, Hofstetter WL, Lee JH, Liao Z, McAleer MF, Maru D, Bhutani MS, Swisher SG, Izzo JG, Ajani JA. Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus. Cancer 113(6):1302-1308, 2008. e-Pub 2008. PMID: 18623381.
Cen P, Hofstetter WL, Correa AM, Wu TT, Lee JH, Ross WA, Davilla M, Swisher SG, Fukami N, Rashid A, Maru D, Ajani JA. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma. Cancer 112(5):1020-7, 2008. e-Pub 2008. PMID: 18205187.
Cen P, Hofstetter WL, Lee JH, Ross WA, Wu TT, Swisher SG, Davila M, Rashid A, Correa AM, Ajani JA. Value of endoscopic ultrasound staging in conjunction with the evaluation of lymphovascular invasion in identifying low-risk esophageal carcinoma. Cancer 112(3):503-10, 2008. e-Pub 2008. PMID: 18072264.
Agarwal B, Correa AM, Ho L. Survival in pancreatic carcinoma based on tumor size. Pancreas 36(1):e15-20, 2008. e-Pub 2008. PMID: 18192868.
Blackmon SH, Patel AR, Bruckner BA, Beyer EA, Rice DC, Vaporciyan AA, Wojciechowski Z, Correa AM, Reardon MJ. Cardiac autotransplantation for malignant or complex primary left-heart tumors. Tex Heart Inst J 35(3):296-300, 2008. e-Pub 2008. PMID: 18941651.
Deus HF, Stanislaus R, Veiga DF, Behrens C, Wistuba II, Minna JD, Garner HR, Swisher SG, Roth JA, Correa AM, Broom B, Coombes K, Chang A, Vogel LH, Almeida JS. A Semantic Web management model for integrative biomedical informatics. PLoS One 3(8):e2946, 2008. e-Pub 2008. PMID: 18698353.
Tetzlaff ED, Correa AM, Komaki R, Swisher SG, Maru D, Ross WA, Ajani JA. Significance of thromboembolic phenomena occurring before and during chemoradiotherapy for localized carcinoma of the esophagus and gastroesophageal junction. Dis Esophagus 22(7):575-81, 2008. e-Pub 2008. PMID: 18459989.
Rice DC, Stevens CW, Correa AM, Vaporciyan AA, Tsao A, Forster KM, Walsh GL, Swisher SG, Hofstetter WL, Mehran RJ, Roth JA, Liao Z, Smythe WR. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 84(5):1685-92; discussion 1692-3, 2007. e-Pub 2007. PMID: 17954086.
Abraham SC, Krasinskas AM, Correa AM, Hofstetter WL, Ajani JA, Swisher SG, Wu TT. Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma. Am J Surg Pathol 31(11):1719-25, 2007. e-Pub 2007. PMID: 18059229.
Yendamuri S, Komaki RR, Correa AM, Allen P, Wynn B, Blackmon S, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran RJ. Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancer. J Thorac Oncol 2(11):1022-8, 2007. e-Pub 2007. PMID: 17975494.
Rice DC, Smythe WR, Liao Z, Guerrero T, Chang JY, McAleer MF, Jeter MD, Correa A, Vaporciyan AA, Liu HH, Komaki R, Forster KM, Stevens CW. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 69(2):350-7, 2007. e-Pub 2007. PMID: 17467922.
Ajani JA, Correa AM, Swisher SG, Wu TT. For localized gastroesophageal cancer, you give chemoradiation before surgery, but then what happens?. J Clin Oncol 25(27):4315-6, 2007. e-Pub 2007. PMID: 17878485.
Bakaeen F, Rice D, Correa AM, Walsh GL, Vaporciyan AA, Putnam JB, Swisher SG, Roth JA, Huh J, Chu D, Smythe WR. Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications. Ann Thorac Surg 84(3):982-6, 2007. e-Pub 2007. PMID: 17720413.
Martin LW, Correa AM, Ordonez NG, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. Sarcomatoid carcinoma of the lung: a predictor of poor prognosis. Ann Thorac Surg 84(3):973-80, 2007. e-Pub 2007. PMID: 17720411.
Izzo JG, Luthra R, Sims-Mourtada J, Chao KSC, Lee JH, Wu TT, Correa AM, Luthra M, Aggarwal B, Hung MC, Ajani JA. Emerging molecular targets in esophageal cancers. Gastrointest Cancer Res 1(4 (Supplement 2)):S3-S6, 2007. e-Pub 2007.
Hofstetter W, Correa AM, Bekele N, Ajani JA, Phan A, Komaki RR, Liao Z, Maru D, Wu TT, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Francis A, Blackmon S, Swisher SG. Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg 84(2):365-73; discussion 374-5, 2007. e-Pub 2007. PMID: 17643602.
Izzo JG, Malhotra U, Wu TT, Luthra R, Correa AM, Swisher SG, Hofstetter W, Chao KS, Hung MC, Ajani JA. Clinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-kappaB expression. Cancer Epidemiol Biomarkers Prev 16(6):1200-5, 2007. e-Pub 2007. PMID: 17548685.
Blackmon SH, AM C, Wynn B, Hofstetter WL, Martin LW, Mehran RJ, Rice DC, Swisher SG, Walsh GL, Roth JA, Vaporciyan AA. Propensity-matched analysis of three techniques for intrathoracic esophagogastric anastomosis. Ann Thorac Surg 83(5):1805-13; discussion 1813, 2007. e-Pub 2007. PMID: 17462404.
Tetzlaff ED, AM C, Baker J, Ensor J, Ajani JA. The impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma. Cancer 109(10):1989-95, 2007. e-Pub 2007. PMID: 17397035.
Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Reseetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Cancer 109(4):658-67, 2007. e-Pub 2007. PMID: 17211865.
Izzo JG, Wu TT, Wu X, Ensor J, Luthra R, Pan J, Correa A, Swisher SG, Chao CK, Hittelman WN, Ajani JA. Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma. J Clin Oncol 25(6):698-707, 2007. e-Pub 2007. PMID: 17308274.
Bruzzi JF, Swisher SG, Truong MT, Munden RF, Hofstetter WL, Macapinlac HA, Correa AM, Mawlawi O, Ajani JA, Komaki RR, Fukami N, Erasmus JJ. Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy. Cancer 109(1):125-34, 2007. e-Pub 2007. PMID: 17146785.
Wu TT, Chirieac LR, Abraham SC, Krasinskas AM, Wang H, Rashid A, Correa AM, Hofstetter WL, Ajani JA, Swisher SG. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome. Am J Surg Pathol 31(1):58-64, 2007. e-Pub 2007. PMID: 17197919.
Herrera LJ, Correa AM, Vaporciyan AA, Hofstetter WL, Rice DC, Swisher SG, Walsh GL, Roth JA, Mehran RJ. Increased risk of aspiration and pulmonary complications after lung resection in head and neck cancer patients. Ann Thorac Surg 82(6):1982-7; discussion 1987-8, 2006. e-Pub 2006. PMID: 17126095.
Izzo JG, Correa AM, Wu TT, Malhotra U, Chao CK, Luthra R, Ensor J, Dekovich A, Liao Z, Hittelman WN, Aggarwal BB, Ajani JA. Pretherapy nuclear factor-kappaB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma. Mol Cancer Ther 5(11):2844-50, 2006. e-Pub 2006. PMID: 17121931.
Wang KL, Yang Q, Cleary KR, Swisher SG, Correa AM, Komaki R, Ajani JA, Rashid A, Hamilton SR, Wu TT. The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation. Cancer 107(7):1467-74, 2006. e-Pub 2006. PMID: 16955509.
Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Wu TT, Swisher SG. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma. Cancer 107(5):967-74, 2006. e-Pub 2006. PMID: 16874819.
Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Albarracin CT. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res 12(15):4598-604, 2006. e-Pub 2006. PMID: 16899607.
Wu X, Gu J, Wu TT, Swisher SG, Liao Z, Correa AM, Liu J, Etzel CJ, Amos CI, Huang M, Chiang SS, Milas L, Hittelman WN, Ajani JA. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol 24(23):3789-98, 2006. e-Pub 2006. PMID: 16785472.
Erasmus JJ, Munden RF, Truong MT, Ho JJ, Hofstetter WL, Macapinlac HA, Correa AM, Wu TT, Bruzzi JF, Marom EM, Sabloff BS, Ajani JA, Komaki R, Liao Z, Lee JH, Fukami N, Bresalier R, Swisher SG. Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging. J Thorac Oncol 1(5):478-86, 2006. e-Pub 2006. PMID: 17409902.
Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter WL, Liao Z, Komaki RR, Rashid A, Hamilton SR, Wu TT. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 106(5):1017-25, 2006. e-Pub 2006. PMID: 16456809.
Liao Z, Liu H, Swisher SG, Wang L, Wu TT, Correa AM, Roth JA, Cox JD, Komaki R, Ajani JA, Wei Q. Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 64(3):700-8, 2006. e-Pub 2006. PMID: 16242255.
Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Rice DC, Bresalier RS, Roth JA, Ajani JA. Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy. Cancer 106(3):552-8, 2006. e-Pub 2006. PMID: 16353210.
Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. J Thorac Cardiovasc Surg 131(1):65-72, 2006. e-Pub 2006. PMID: 16399296.
Rohatgi PR, Correa AM, Swisher SG, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Lee JH, Rice DC, Roth JA, Ajani JA. Gender-based analysis of esophageal cancer patients undergoing preoperative chemoradiation: differences in presentation and therapy outcome. Dis Esophagus 19(3):152-7, 2006. e-Pub 2006. PMID: 16722991.
Izzo JG, Malhotra U, Wu TT, Ensor J, Babenko IM, Swisher SG, Correa A, Bresalier RS, Hittelman WN, Ajani JA. Impact of cyclin D1 A870G polymorphism in esophageal adenocarcinoma tumorigenesis. Semin Oncol 32(6 Suppl 9):S11-5, 2005. e-Pub 2005. PMID: 16399423.
Martin LW, Correa AM, Hofstetter W, Hong WK, Komaki R, Putnam JB, Rice DC, Smythe WR, Swisher SG, Vaporciyan AA, Walsh GL, Roth JA. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution. J Thorac Cardiovasc Surg 130(6):1601-10, 2005. e-Pub 2005. PMID: 16308005.
Rohatgi P, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Rice DC, Roth JA, Ajani JA. Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Cancer 104(11):2365-72, 2005. e-Pub 2005. PMID: 16245310.
Onn A, Choe DH, Herbst RS, Correa AM, Munden RF, Truong MT, Vaporciyan AA, Isobe T, Gilcrease MZ, Marom EM. Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome. Radiology 237(1):342-7, 2005. e-Pub 2005. PMID: 16183941.
Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh G, Vaporciyan A, Lynch PM, Rice DC, Roth JA, Ajani JA. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer 104(7):1349-55, 2005. e-Pub 2005. PMID: 16130133.
Martin LW, Swisher SG, Hofstetter W, Correa AM, Mehran RJ, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Intrathoracic leaks following esophagectomy are no longer associated with increased mortality. Ann Surg 242(3):392-9; discussion 399-402, 2005. e-Pub 2005. PMID: 16135925.
Liu L, Hofstetter WL, Rashid A, Swisher SG, Correa AM, Ajani JA, Hamilton SR, Wu TT. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol 29(8):1079-85, 2005. e-Pub 2005. PMID: 16006804.
Agarwal B, Gogia S, Eloubeidi MA, Correa AM, Ho L, Collins BT. Malignant mediastinal lymphadenopathy detected by staging EUS in patients with pancreaticobiliary cancer. Gastrointest Endosc 61(7):849-53, 2005. e-Pub 2005. PMID: 15933686.
Swisher SG, Hofstetter W, Wu TT, Correa AM, Ajani JA, Komaki RR, Chirieac L, Hunt KK, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg 241(5):810-7; discussion 817-20, 2005. e-Pub 2005. PMID: 15849517.
Agarwal B, Swisher SG, Ajani J, Kelly K, Komaki RR, Abu-Hamda E, Correa AM, Roth JA. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux. Ann Thorac Surg 79(5):1716-23, 2005. e-Pub 2005. PMID: 15854962.
Chirieac LR, Swisher SG, Ajani JA, Komaki RR, Correa AM, Morris JS, Roth JA, Rashid A, Hamilton SR, Wu TT. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer 103(7):1347-55, 2005. e-Pub 2005. PMID: 15719440.
Chirieac LR, Swisher SG, Correa AM, Ajani JA, Komaki RR, Rashid A, Hamilton SR, Wu TT. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma. Clin Cancer Res 11(6):2229-36, 2005. e-Pub 2005. PMID: 15788671.
Rice DC, Correa AM, Vaporciyan AA, Sodhi N, Smythe WR, Swisher SG, Walsh GL, Putnam JB, Komaki R, Ajani JA, Roth JA. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity. Ann Thorac Surg 79(2):391-7; discussionn 391-7, 2005. e-Pub 2005. PMID: 15680801.
Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Walsh GL, Vaporciyan AA, Rice DC, Fukami N, Roth JA, Ajani JA. Comparison of clinical stage, therapy response, and patient outcome between squamous cell carcinoma and adenocarcinoma of the esophagus. Int J Gastrointest Cancer 36(2):69-76, 2005. e-Pub 2005. PMID: 16648656.
Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK, Putnam JB, Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 101(8):1776-85, 2004. e-Pub 2004. PMID: 15386332.
Agarwal B, Swisher S, Ajani J, Kelly K, Fanning C, Komaki RR, Putnam JB, Abu-Hamda E, Molke KL, Walsh GL, Correa AM, Ho L, Liao Z, Lynch PM, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol 99(7):1258-66, 2004. e-Pub 2004. PMID: 15233663.
Agarwal B, Abu-Hamda E, Molke KL, Correa AM, Ho L. Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am J Gastroenterol 99(5):844-50, 2004. e-Pub 2004. PMID: 15128348.
Vaporciyan AA, Correa AM, Rice DC, Roth JA, Smythe WR, Swisher SG, Walsh GL, Putnam JB. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg 127(3):779-86, 2004. e-Pub 2004. PMID: 15001907.
Onn A, Correa AM, Gilcrease M, Isobe T, Massarelli E, Bucana CD, O'Reilly MS, Hong WK, Fidler IJ, Putnam JB, Herbst RS. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer. Clin Cancer Res 10(1 Pt 1):136-43, 2004. e-Pub 2004. PMID: 14734462.
Swisher SG, Ajani JA, Komaki R, Nesbitt JC, Correa AM, Cox JD, Lahoti S, Martin F, Putnam JB, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 57(1):120-7, 2003. e-Pub 2003. PMID: 12909224.
Swisher SG, Roth JA, Komaki R, Gu J, Lee JJ, Hicks M, Ro JY, Hong WK, Merritt JA, Ahrar K, Atkinson NE, Correa AM, Dolormente M, Dreiling L, El-Naggar AK, Fossella F, Francisco R, Glisson B, Grammer S, Herbst R, Huaringa A, Kemp B, Khuri FR, Kurie JM, Liao Z, McDonnell TJ, Morice R, Morello F, Munden R, Papadimitrakopoulou V, Pisters KM, Putnam JB, Sarabia AJ, Shelton T, Stevens C, Shin DM, Smythe WR, Vaporciyan AA, Walsh GL, Yin M. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Clin Cancer Res 9(1):93-101, 2003. e-Pub 2003. PMID: 12538456.
Hofstetter W, Swisher SG, Correa AM, Hess K, Putnam JB, Ajani JA, Dolormente M, Francisco R, Komaki RR, Lara A, Martin F, Rice DC, Sarabia AJ, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Treatment outcomes of resected esophageal cancer. Ann Surg 236(3):376-84; discussion 384-5, 2002. e-Pub 2002. PMID: 12192324.
Vaporciyan AA, Rice D, Correa AM, Walsh G, Putnam JB, Swisher S, Smythe R, Roth J. Resection of advanced thoracic malignancies requiring cardiopulmonary bypass. Eur J Cardiothorac Surg 22(1):47-52, 2002. e-Pub 2002. PMID: 12103372.
Swisher SG, Wynn P, Putnam JB, Mosheim MB, Correa AM, Komaki RR, Ajani JA, Smythe WR, Vaporciyan AA, Roth JA, Walsh GL. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 123(1):175-83, 2002. e-Pub 2002. PMID: 11782772.
Collazo V, Correa AM, Salzberg PM. Revisiting Euclid's Algorithm, a geometric point of view. Congressus Numeratium, Utilitas Mathematica Publs., Winnipeg, Canada 104:7-17, 1994. e-Pub 1994.
Correa A, Cruz R, Salzberg PM. On a spatial limited angle model for x-ray computerized tomography. Tomography, Impedance Imaging and Integral Geometry, Lectures in Applied Mathematics, A.M.S 30:25-33, 1994. e-Pub 1994.

Review Articles

Swisher SG, Maish M, Erasmus JJ, Correa AM, Ajani JA, Bresalier R, Komaki R, Macapinlac H, Munden RF, Putnam JB, Rice D, Smythe WR, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78(4):1152-60; discussion 1152-60, 2004. e-Pub 2004. PMID: 15464463.

Professional Educational Materials

Correa A. Modeling a Health Promotion Campaign Process. Dissertation, 2000.
Correa A. Study of the Power of other Statistical Tests Alternate to X2. Thesis, 1995.

Abstracts

Kassab C, Mitchell K, Correa A, Eisenberg M, Ries S, Antonoff M, Mehran R, Rajaram R, Rice D, Swisher S, Vaporciyan A, Walsh G, Hofstetter W. Successful Management of Post Esophagectomy Anastomotic Leak Nullifies its Effect on Long Term Survival. The Western Thoracic Surgical Association 2024, 2024. e-Pub 2024.
Elmorsi R, Camacho L, Krijgh DD, Tilney GS, Lyu H, Traweek RS, Witt RG, Roubaud MS, Correa AM, Roland CL, Largo RD, Mericli AF. When To Skip the Ladder and Take the Elevator: Complex Reconstructions May Yield a More Reliable Outcome When Reconstructing Defects after Resection of Soft Tissue Sarcomas Located in the Thigh. Plastic Surgery Research Council 2024-69th Annual Meeting, 2024. e-Pub 2024.
Elmorsi R, Camacho L, Krijgh DD, Tilney GS, Lyu H, Traweek RS, Witt RG, Roubaud MS, Correa AM, Roland CL, Largo RD, Mericli AF. Reconstructing Soft Tissue Sarcoma Patients: Tumor Bed Excision Defects are Deceiving and Result in Higher Reoperation Rates. Plastic Surgery Research Council 2024-69th Annual Meeting, 2024. e-Pub 2024.
Krijgh DD, Hassan AM, Smith JM, Tilney G, Lyu H, Traweek RS, Witt RG, Roubaud MJ, Correa AM, Roland CL, Mericli AF. Identifying risk factors and analyzing reconstructive outcomes in patients with lower extremity soft tissue sarcoma. European Plastic Surgery Research Council-14th Meeting, 2023. e-Pub 2023.
Deboever N, Correa A, Feldman H, Eisenberg, M, Antonoff M, Mehran R, Rajaram R, Rice D, Roth J, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Hofstetter W. Early Interventional Treatment of High Output Chyle Leak Following Esophagectomy is Associated with Improved Survival. American Association for Thoracic Surgery 2023, 2023. e-Pub 2023.
Nelson DB, Pataer A, Correa AM, Weissferdt A, Antonoff MB, Cascone T, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Walsh GL, Roth JA, Vaporciyan AA, Heymach JV, Bi S, Swisher SG. Relevance of Pathologic Downstaging After Neoadjuvant Chemotherapy for Lung Cancer. General Thoracic Surgical Club (GTSC) 2023, 2023. e-Pub 2023.
Nelson DB, Pataer A, Correa AM, Deboever N, Weissferdt A, Antonoff MB, Cascone T, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Walsh GL, Roth JA, Vaporciyan AA, Heymach JV, Sepesi B, Swisher SG. Relevance of Pathologic Downstaging After Neoadjuvant Chemotherapy for Lung Cancer. General Thoracic Surgical Club, 2023. e-Pub 2023.
Mericli AF, Chu CKC, Nguyen TT, Correa A. Breast Conserving Therapy and Oncoplastic Reconstruction in the Augmented Woman. Mountain West Society of Plastic Surgeons Annual Meeting, 2023. e-Pub 2023.
Hofstetter WL, Goltsov AA, Katkhuda R, Duose DY, Luthra R, Correa AM, Wang F, Futreal AP, Maru DM. Transcriptomic analysis of esophageal adenocarcinoma archived surgical samples with Nanostring PanCancer panels reveals ANPEP/CD13 is associated with lymphovascular invasion and survival. The Society of Thoracic Surgeons 2023 - 59th Annual Meeting, 2023. e-Pub 2023.
Deboever N, Correa A, Feldman H, Antonoff M, Vaporciyan A, Hofstetter W, Rajaram R. Surgical Outcomes of Early-Stage Lung Cancer at Minority-Serving Hospitals Compared to Non-Minority-Serving Hospitals. American Association for Thoracic Surgery, 2022. e-Pub 2022.
Khanduri I, Correa AM, Krishnaramanujam R, Katkhuda R, Verma A, Mejia A, Tong Z, Mitra A, Soto LMS, Wistuba I, Hofstetter WL, Parra ER, Maru D. Distribution and Significance of T cell Phenotypes in Immune Microenvironment of Esophageal Adenocarcinoma and Barrett’s Esophagus. United States & Canadian Academy of Pathology’s, 2022. e-Pub 2022.
Zhou N, Rice DC, Mehran RJ, Feldman HA, Tomczak K, Hofstetter WL, Vaporciyan AA, Correa AM, Zhang J, Haymaker CL, Tsao AS, Sepesi B. Association between Baseline Tumor Thickness and Response to Neoadjuvant Chemotherapy in Malignant Pleural Mesothelioma. IASLC 2020 World Conference on Lung Cancer, 2021. e-Pub 2021.
Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa A, Badgwell BD, Hofstetter WL. Predictors Of Mediastinal Involvement After Neoadjuvant Chemoradiation In Adenocarcinoma Of The Gastroesophageal Junction. Southern Thoracic Surgical Association, 2018. e-Pub 2018.
Nelson DB, Mehran RJ, Mitchell KG, Van Haren RM, Mena GE, Woodard T, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Heymach JV, Rice DC. Adjuvant Chemotherapy is Facilitated by Enhanced Recovery After Thoracic Surgery. 2018 AATS International Thoracic Surgical Oncology Summit, 2018. e-Pub 2018.
Mohammad ZB, Nelson DB, Lapid D, Correa AM, Mitchell KG, Hofstetter WL, Mehran RJ, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Rice DC, Antonoff MB. Sex-Related Outcomes after Lobectomy for Stage I Non-Small Cell Lung Cancer: A Single Institution Experience. 2018 AATS International Thoracic Surgical Oncology Summit, 2018. e-Pub 2018.
Nelson DV, Tayob N, Mitchell KG, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Mehran RJ. Close Surgical Margins and Risks of Local Treatment Failure after Wedge Resection of Colorectal Pulmonary Metastases. American Association for Thoracic Surgery 98th Annual Meeting, 2018. e-Pub 2018.
Van Haren RM, Mehran R, Correa AM, Antonoff MB, Baker CM, Hofstetter WL, Mena GE, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. Enhanced Recovery Protocol Decreases Pulmonary and Cardiac Complications Following Thoracotomy for Primary Lung Cancer. Society of Thoracic Surgeons, 2018. e-Pub 2018.
Nelson D, Godoy M, Benveniste M, Shewale J, Correa A, Spicer J, Hofstetter W, Mehran R, Rice D, Sepesi B, Walsh G, Vaporciyan A, Swisher S, Roth J, Antonoff M. Clinicoradiographic Predictors of Aggressive Behavior in Resected Malignant Ground glass Opacity Lesions. Western Thoracic Surgical Assoication, 2017. e-Pub 2017.
Rice D, Mehran R, Correa A, Antonoff M, Hofstetter W, Roth J, Sepesi B, Swisher S, Walsh G, Vaporciyan A. Is There Any Value To Robotic Assisted Lobectomy for Lung Cancer?. 2017 ISMICS Annual Scientific Meeting, 2017. e-Pub 2017.
Nelson DB, Lapid DJ, Mitchell KG, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff MB. Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and Women. AATS 2017, 2017. e-Pub 2017.
Sepesi B, Cuentes EP, Canales J, Behrens C, Correa A, Antonoff M, Gibbons D, Heymach J, Hofstetter W, Mehran R, Rice D, Roth J, Vaporciyan A, Walsh G, Weissferdt A, Kalhor N, Moran C, Swisher S, Wistuba I. Tumor Infiltrating Lymphocytes and Overall Survival in Surgically Resected Stage II and III Non-Small Cell Lung Cancer. Multidisciplinary Thoracic Cancers Symposium 98(1):223, 2017. e-Pub 2017.
Cuentas ER, Behrens C, Rodriguez-Canales J, Jiang M, Pataer A, Correa A, Swisher S, Sepesi B, Weissferdt A, Kalhor N, Zhang J, Lee J, Heymach J, Moran C, Zhang J, Gibbons D, Wistuba I. Neoadjuvant chemotherapy influence changes of the immune response in non-small cell lung carcinomas immune response in non-small cell lung carcinomas. American Association for Cancer Research, 2017. e-Pub 2017.
Nelson DB, Correa AM, Dhupar R, Goltsov A, Maru D, Sepesi B, Antonoff M, Mehran RJ, Rice DC, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Davila R, Betancourt S, Skinner H, Blum M, Hofstetter WL. Endoscopic Mucosal Resection for Submucosal Esophageal Cancer. American Association for Thoracic Surgery:79, 2017. e-Pub 2017.
Liu X, Sepesi B, Gold KA, Correa AM, Heymach JV, Vaporciyan AA, Roszik J, Dmitrovsky E. The influence of body mass index on overall survival following surgical resection of non-small cell lung cancer. American Association for Cancer Research, 2017. e-Pub 2017.
Antonoff M, Correa A, Sepesi B, Rice D, Hofstetter W, Mehran R, Vaporciyan A, Walsh G, Swisher S, Roth J. Ground Glass Lesions on Chest Imaging: Evaluation of Reported Incidence with Use of Natural Language Processing. American Association for Thoracic Surgery 2017, 2017. e-Pub 2017.
Bassuner J, Rice DC, Antonoff MB, Correa A, Walsh GL, Vaporciyan AA, Garg N, Sepesi B, Swisher SG, Hofstetter WL, Roth JA, Mehran RJ. Polytetrauoroethylene or Collagen Matrix for Diaphragmatic Reconstruction?. Society of Thoracic Surgeons, 2017. e-Pub 2017.
Mehran RJ, Walsh GL, Zalpour A, Cata JP, Correa AM, Antonoff MB, Rice DC. Intercostal nerve blocks with Liposomal Bupivacaine: Demonstration of Safety, Feasibility, and Potential Benefits. Seminars in Thoracic and Cardiovascular Surgery, 2017. e-Pub 2017.
Parra ER, Rodriguez-Canales J, Behrens C, Jiang M, Pataer A, Correa AM, Swisher S, Sepesi B, Weissferdt A, Kalhor N, William Jr WN, Lee JJ, Heymach J, Moran C, Zhang J, Gibbons DL, Wistuba I. The Influence of Neoadjuvant Chemotherapy, on Immune Response Profile in Non-Small Cell Lung Carcinomas. World Conference on Lung Cancer, 2016. e-Pub 2016.
Atay S, Correa A, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan A, Walsh G, Antonoff M. Perioperative Outcomes of Patients Undergoing Pulmonary Lobectomy on Clopidogrel. Southern Thoracic Surgical Association, 2016. e-Pub 2016.
Sceusi E, Scott A, Correa A, Swisher S, Vaporciyan A, Roth J, Walsh G, Hofstetter W, Mehran R, Rice D, Sepesi B, Antonoff M. Outcomes for Patients with Surgically Resected Thymic Neuroendocrine Tumors. North American Neuroendocrine Tumor Society, 2016. e-Pub 2016.
Sepesi B, Parra Cuentas E, Rodriguez Canales J, Behrens C, Correa A, Antonoff M, Gibbons D, Heymach J, Hofstetter W, Mehran R, Rice D, Roth J, Vaporciyan A, Walsh G, Weissferdt A, Kalhor N, Moran C, Swisher S, Wistuba I. The Expression Of Programmed Death 1 Ligand (PD-L1) in the Tumor and Tumor Infiltrating Macrophages Predicts Overall and Disease Free Survival in Surgically Resected Pathologic Stage I Non-Small Cell Lung Cancer. Western Thoracic Surgical Association, 2016. e-Pub 2016.
Sceusi E, Leiva-Juarez M, Mehran R, Kalhor N, Shaw K, Futreal A, Correa A, Moran C, Wistuba II, Rao X, Swisher S, Vaporciyan A, Wang J, Antonoff, Hofstetter W, Rice D, Sepesi B, Walsh G, Roth J. Well Differentiated Neuroendocrine Carcinoma (Typical Carcinoid) with Mediastinal Lymph Node Metastases: Surgical Outcomes and Whole Exome Sequencing (WES). American Association for Thoracic Surgery, 2016. e-Pub 2016.
Lopez C, Correa A, Vaporciyan A, Austin M, Rice D, Hayes-Jordan A. Outcomes of Chest Wall Resections in Pediatric Sarcoma Patients. American Pediatric Surgical Association, 2016. e-Pub 2016.
Antonoff MB, Correa A, Sepesi B, Nguyen Q, Walsh G, Swisher S, Vaporciyan A, Mehran R, Hofstetter W, Rice D. Salvage pulmonary resection following SBRT: A feasible and safe option for local failure. American Association for Thoracic Surgery, 2016. e-Pub 2016.
Pataer A, Hao C, Correa AM, Weissferdt A, Behrens C, Wistuba II, Swisher SG. PKR and Jagged1 associated with lymph node metastasis in lung cancer. American Association for Cancer Research, 2016. e-Pub 2016.
Spicer JD, Shewale JB, Antonoff MB, Correa AM, Hofstetter W, Rice DC, Vaporciyan A, Mehran R, Walsh GL, Roth JA, Swisher SG, Sepesi B. The Influence of Reconstructive Technique on Perioperative Outcomes Following Chest Wall Resection. Southern Thoracic Surgical Association, 2015. e-Pub 2015.
Sanchez N, Shewale JB, Baker C, Wilks SA, Correa AM, Sepesi B, Mehran R, Rice DC, Roth JA, Walsh GL, Swisher SG, Vaporciyan A, Hofstetter W. Implications of Early Foley Removal in Thoracic Surgical Oncology Patients Utilizing Epidural Analgesia. Southern Thoracic Surgical Association, 2015. e-Pub 2015.
Merrell KW, Hallemeier CL, James SE, Bhooshan N, Wang L, Correa AM, Liao Z, Thall PF, Komaki RU, Suntharalingam M, Mehta MP, Mehran RJ, Haddock MG, Chuong MD, Lin SH. Comparison of Overall Survival for Esophageal Cancer Patients Treated With Neoadjuvant Proton or Photon Chemoradiation: A Multi-institutional Analysis. American Society for Therapeutic Radiology and Oncology, 2015. e-Pub 2015.
Lin SH, Merrell KW, Bhooshan N, Correa AM, James SE, Haddock MG, Liao Z, Komaki RU, Suntharalingam M, Mehta MP, Chuong MD, Hallemeier CL, Mehran RJ. Radiation Modality Use and the Incidence of Postoperative Complications and Length of Hospitalization After Trimodality Therapy for Esophageal Cancer: A Multi-institutional Analysis. American Society for Therapeutic Radiology and Oncology, 2015. e-Pub 2015.
Spicer J, Shewale J, Sepesi B, Antonoff M, Correa A, Hofstetter W, Rice D, Vaporciyan A, Mehran R, Walsh G, Roth J, Swisher S. The Role of Pneumonectomy After Neoadjuvant Chemotherapy for N2 Non-¬‐Small Cell Lung Cancer. Canadian Association of Thoracic Surgeons and Canadian Surgery Forum, 2015. e-Pub 2015.
Spicer JD, Shewale J, Correa AM, Heymach JV, Antonoff MB, Hofstetter W, Mehran R, Roth J, Rice D, Sepesi B, Vaporciyan AA, William W, Walsh G, Swisher S. Pre-Operative Chemotherapy Followed by Surgery for N2 Non-Small Cell Lung Cancer: A 15-Year Experience. World Conference on Lung Cancer, 2015. e-Pub 2015.
Spicer J, Stiles B, Sudarshan M, Correa A, Ferri L, Altorki N, Hofstetter W. Preoperative Chemoradiation Therapy vs Chemotherapy in Patients Undergoing Modified En Bloc Esophagectomy for Locally Advanced Esophageal Adenocarcinoma: Does Radiation Add Value?. Canadian Association of Thoracic Surgeons and Canadian Surgery Forum, 2015. e-Pub 2015.
Naidoo J, Sepesi B, Woo KM, Sima CS, Dycoco J, Tang H, Childs B, Travis WD, Rusch VW, Finley DJ, Correa AM, Vaporciyan A, Kris MG, Zauderer MG. Multiple Lung Cancers: Can their prognosis guide how we treat them?. World Conference on Lung Cancer, 2015. e-Pub 2015.
Gold KA, Sepesi B, Correa AM, Liu X, Heymach JV, VAporciyan AA, Dmitrovsky E. The Influence of Body Mass Index on Overall Survival following Surgical Resection of Non-Small Cell Lung Cancer. World Conference on Lung Cancer, 2015. e-Pub 2015.
Antonoff MB, Ragalie W, Correa AM, Spicer JD, Sepesi B, Roth JA, Walsh GL, WlL H, Swisher SG, Rice DC, Vaporciyan AA, Mehran RJ. Indications For Counseling And Intervention After Pulmonary Resection: Results Of Post-discharge Nursing Telephone Assessments. Western Thoracic Surgical Association, 2015. e-Pub 2015.
Blum MA, Xiao L, Correa A, Wadhwa R, Skinner HD, Elimova E, Komaki R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Analysis of Patients with Esophageal Cancer Following Trimodality Therapy: Pathological Complete Remission (PathCR) versus Non-PathCR. American Society of Clinical Oncology, 2015. e-Pub 2015.
Zhang J, Liu Y, Zhang J, Gomez D, Fujimoto J, Behrens C, Zhang J, Correa A, Gumbs C, Mao X, Seth S, Song X, Heymach J, Lee JJ, Swisher S, William W, Hong WK, Gao Y, Wistuba I, Futreal A. Genomic heterogeneity of lung cancers and its potential clinical implications. American Society of Clinical Oncology, 2015. e-Pub 2015.
Hallemeier CL, Chuong M, Merrell KW, James SE, Haddock MG, Bhooshan N, Mehta M, Correa AM, Liao Z, Mehran R, Lin SH. Impact of neoadjuvant proton vs. photon chemoradiotherapy (CRT) on post-operative outcomes in patients with esophageal cancer treated with trimodality therapy – a multi-institutional analysis. Particle Therapy Cooperative Group, 2015. e-Pub 2015.
Pataer A, Ruping S, Correa AM, Carmen, Roth JA, Wistuba II, Swisher SG. Evaluate biomarkers in NSCLC tumors receiving neoadjuvant chemotherapy. Proc Am Assoc Cancer Res, 2015. e-Pub 2015.
Spicer J, Stiles BM, Sudarshan M, Correa A, Ferri LE, Altorki NK, Hofstetter WL. Preoperative Chemoradiation Therapy vs Chemotherapy in Patients Undergoing En Bloc Esophagectomy for Locally Advanced Esophageal Adenocarcinoma: Does Radiation Add Value?. Society of Thoracic Surgeons, 2015. e-Pub 2015.
Antonoff MB, Hofstetter WL, Correa A, Bell J, Swisher SG, Meyers BF. Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small Cell Lung Cancer: Is There a Role for Selective Surgery?. Society of Thoracic Surgeons, 2015. e-Pub 2015.
Dhupar R, Correa A, Rice R, Bhutani M, Weston B, DaSilva A, Maru D, Betancourt S, Rice DC, Swisher SG, Hofstetter WL. Endoscopic Ultrasound Estimates for Tumor Depth at the Gastroesophageal Junction Are Less Accurate for Early Mid-Stage Patients: Implications for the Liberal Use of Endoscopic Resection. Society of Thoracic Surgeons, 2015. e-Pub 2015.
Stephens E, Gaur P, Hotze K, Correa A, Kim M, Blackmon S. Super-charged Pedicled Jejunal Interposition Performance Compares Favorably to a Gastric Conduit After Esophagectomy. Southern Thoracic Surgical Association, 2014. e-Pub 2014.
Sepesi B, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Walsh GL, Swisher SG, Hofstetter WL. Trends and Improving Outcomes of 882 Surgical Patients With Gastro-Esophageal Junction Adenocarcinoma – A Single Institution Experience. The International Society for Diseases of the Esophagus 2014(130), 2014. e-Pub 2014.
Pataer A, Guo C, Shao R, Correa AM, Behrens C, Fang B, Roth JA, Wistuba II, Swisher SG. Nutrient depletion caused by PKR induces phosphorylation of AMPK in lung cancer. American Association for Cancer Research, 2014. e-Pub 2014.
Study Group TEC. A multi‐institutional study on staging deficiencies, treatment patterns, and outcomes in cT2N0 esophageal cancer. American Association of Thoracic Surgeons, 2014. e-Pub 2014.
Francis AM, Correa AM, Betancourt-Cuellar SL, Kim JY, Sepesi B, Ajani JA, Komaki R, Erasmus J, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Hofstetter WL, Swisher SG. Esophageal Tumor Thickness on Computed Tomography as a Predictor of Residual Tumor in Esophageal Adenocarcinoma Following Preoperative Chemoradiation. Association for Academic Surgery and Society of University Surgeons, 2014. e-Pub 2014.
Betancourt-Cuellar SL, Hofstetter WL, Correa AM, Mawlawi OR, Palacio DM, Marom EM. Prognostic Value of Metabolic Tumor Volume in Patients with Esophageal Carcinoma. Radiological Society of North America, 2013. e-Pub 2013.
Palacio DM, Hofstetter WL, Correa AM, Betancourt-Cuellar SL, Marom EM. Diagnosing Leak after Esophagectomy for Esophageal Cancer by CT-esophageal Protocol (CTEP) and Standard Esophagram (SE): Is the Old School Still the Best School?. Radiological Society of North America, 2013. e-Pub 2013.
Kim MP, Correa AM, Blackmon SH, Hofstetter W, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Preoperative Flourodeoxyglucose-Positron Emission Tomography Scan with Positive N1 Disease Does Not Predict Worse Survival in Pathologic Stage II Patients. IASLC 2013, 2013. e-Pub 2013.
Taketa T, Correa AM, Sudo K, Blum MA, Wadhwa R, Skinner HD, Komaki R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Customizing surveillance of patients with esophageal or esophagogastric junction adenocarcinoma (E-EGA) after trimodality therapy (TMT). American Society of Clinical Oncology, 2013. e-Pub 2013.
Francis AM, Sepesi B, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG, Hofstetter WL. Long-term Survival and Recurrence Rates Following Trimodality Therapy of Esophageal Adenocarcinoma - The Influence of Histologic Tumor Viability. American Surgical Association, 2013. e-Pub 2013.
Sepesi B, Correa AM, Pataer A, Kalhor N, Bekele BN, Erasmus JJ, Hofstetter W, Kim ES, Komaki R, Mehran RJ, Moran CA, Papadimitrakopoulou V, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, William WN, Wistuba I, Swisher SG. The Impact of Histopathologic Response on Pathologic TNM Lung Cancer Staging System (AJCC Seventh) Following Neoadjuvant Chemotherapy. The Society of Thoracic Surgeons, 2013. e-Pub 2013.
Campagna M, Taketa T, Correa AM, Sudo K, Blum MA, Wadhwa R, Komaki R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Association of relapse in patients with esophageal and esophagogastric junction (E-EGJ) cancer with surgical stage after trimodality therapy (TMT): Implications for customized surveillance. Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
David EA, Wai C, Correa AM, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Thall PF, Mehran RJ. Visceral Pleural Invasion Is Not Predictive of Survival in NSCLC Patients with Small Tumors in a North American Patient Population. The Society of Thoracic Surgeons, 2013. e-Pub 2013.
Subbiah IM, Blackmon SH, Correa AM, Kee BK, Vaporciyan AA, Swisher S, Eng C. Preoperative chemotherapy prior to pulmonary metastatecomy in patients with prior surgically resected primary colorectal carcinoma. Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
Wadhwa R, Taketa T, Correa AM, Sudo K, Blum MA, Campagna M, Komaki R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Incidence of brain metastases following trimodality therapy (TMT) in patients with esophageal and gastroesophageal (E-EGCJ) cancer. Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
Sudo K, Taketa T, AM C, Campagna M, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, Liao ZX, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Association of trimodality therapy (TMT) with rate of local-regional relapse and rare luminal-only relapse for patients with esophageal and esophagogastric junction (E-EGJ) cancer: Implications for the surveillance strategy. Gastrointestinal Cancers Symposium, 2013. e-Pub 2013.
Hofstetter WL, Ganeshan DM, Correa AM, Bhosale P, Vaporciyan AA, Rice D, Mehran RJ, Walsh GL, Iyer R, Roth JA, Swisher SG. Diaphragmatic Hernia After Esophagectomy in 440 Patients With Long-Term Follow-Up. The Southern Thoracic Surgical Association, 2012. e-Pub 2012.
Marom EM, Moran CA, Liu P, Correa AM, Kim ES, Komaki R, Erasmus JJ, Hofstetter WL, Rice DC, Swisher SG. Computed Tomography Findings Predicting Invasiveness of Thymoma. International Society of Oncology and Biomarkers, 2012. e-Pub 2012.
Lou F, Amini A, Correa AM, Baldassarre RL, Rimner A, Roth JA, Swisher S, Huang J, Vaporciyan AA, Lin SH. Predictors for locoregional recurrence for clinical stage III-N2 non-small cell lung cancer with nodal downstaging after induction chemotherapy and surgery. American Society of Clinical Oncology, 2012. e-Pub 2012.
Taketa T, AM C, Suzuki A, Blum MA, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Outcome of 58 trimodality-eligible esophagogastric cancer (EC) patients who achieved clinical complete response (cCR) after preoperative chemoradiation but then declined surgery. American Society of Clinical Oncology, 2012. e-Pub 2012.
Cheedella NKS, Suzuki A, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Maru DM, Vaporciyan AA, Taketa T, Blum MA, Welsh J, Lin SH, Lee JH, Bhutani MS, Weston B, Walsh GL, Swisher S, Ajani JA. Association of clinical complete response (cCR) after preoperative chemoradiation and pathological complete response (pathCR) in patients with gastroesophageal cancer (GEC) and indispensability of trimodality therapy (TMT). American Society of Clinical Oncology, 2012. e-Pub 2012.
Guo C, Shao R, Correa AM, Behrens C, Fang B, Roth JA, Wistuba II, Swisher SG, Lin T, Pataer A. Prognostic significance of combinations of RNA-dependent protein kinase and EphA2 biomarkers for NSCLC. American Association for Cancer Research, 2012. e-Pub 2012.
Sepesi B, Swisher SG, Walsh GL, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Hofstetter WL. Omental Reinforcement of the Thoracic Esophagogastric Anastomosis—An Analysis of Leak and Reintervention Rates in Planned and Salvage Esophagectomy Patients. American Association for Thoracic Surgery, 2012. e-Pub 2012.
Taketa T, Correa AM, Suzuki A, Blum MA, Lee JE, Welsh J, Lin SH, Maru D, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Outcome of trimodality-eligible esophagogastric cancer (EC) patients who declined surgery after preoperative chemoradiation. Gastrointestinal Cancers Symposium, 2012. e-Pub 2012.
Kim JY, Hildebrandt MA, Pu X, Ye Y, Correa AM, Vaporciyan AA, Wu X, Roth JA. Genetic Variations in the VEGF Pathway are Associated With Postoperative Pulmonary Complications After Lung Resection. The Society of Thoracic Surgeons, 2012. e-Pub 2012.
Marks JL, Hofstetter WL, Correa AM, Mehran RJ, Rice DC, Roth JA, Walsh GL, Vaporciyan AA, Erasmus J, Chang J, Maru D, Lee JH, Lee J, Ajani JA, Swisher SG. Salvage Esophagectomy After Failed Definitive Chemoradiation for Esophageal Adenocarcinoma. The Society of Thoracic Surgeons, 2012. e-Pub 2012.
Blackmon SH, Correa AM, Skoracki R, Chevray PM, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Yu P, Hofstetter WL. Super-Charged Pedicled Jejunal Interposition for Esophageal Replacement: A 10-Year Experience. The Society of Thoracic Surgeons, 2012. e-Pub 2012.
Blackmon SH, Stephens E, Correa AM, Hofstetter WL, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA. Predictors of Recurrence in the Lung and Survival in Pulmonary Metastasectomy for Colorectal Carcinoma Patients. The Society of Thoracic Surgeons, 2012. e-Pub 2012.
Amini A, Lin SH, Correa AM, Swisher SG, Roth JA, Vaporciyan AA. Locoregional Recurrence Rate in Resected Stage III-N2 Non-Small Cell Lung Cancers (NSCLC) with Nodal Downstaging following Induction Chemotherapy. Int J Radiat Oncol Biol Phys 81(2):S134, 2011. e-Pub 2011.
Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Suzuki A, Lee JH, Bhutani MS, Lin HS, Welsh J, Maru D, Swisher S, Ajani JA. The association between body mass index and baseline clinical stage of esophageal carcinoma. American Society of Clinical Oncology, 2011. e-Pub 2011.
He Y, Zhou Z, Hofstetter WL, Zhou Y, Hu W, Pataer A, Correa AM, Lu Y, Wang J, Diao L, Byers LA, Wistuba I, Roth JA, Swisher SG, Heymach JV, Fang B. Aberrant Signal Transduction and DNA Damage Response pathways in Primary Lung Cancer. World Conference on Lung Cancer, 2011. e-Pub 2011.
Harvin JA, Lahat G, Correa AM, Lee JJ, Maru D, Ajani JA, Marom EM, Welsh J, Walsh GL, Roth JA, Mehran RJ, Vaporciyan AA, Rice DC, Swisher SG, Hofstetter WL. Neoadjuvant Chemoradiation Followed by Surgery for Esophageal Adenocarcinoma: Significance of Microscopically Positive Circumferential Margins. American Association for Thoracic Surgery, 2011. e-Pub 2011.
Pataer A, He Y, Correa AM, Fang B, Roth JA, Wistuba II, Swisher SG. PKR signaling pathway plays an important role in prognosis for non-small cell lung cancer. American Association for Cancer Research, 2011. e-Pub 2011.
Hildebrantdt MA, Roth JA, Vaporciyan AA, Pu X, Ye Y, Correa AM, Kim JY, Swisher SG. Genetic variation in the p38 signaling pathway as markers for postoperative pulmonary complications in lung cancer patients. American Association for Cancer Research, 2011. e-Pub 2011.
Estrella JS, Hofstetter W, Correa AM, Ajani J, Swisher S, Rashid A, Maru D. Measurement of Depth of Invasion, Submucosal and Lymphovascular Invasion (LVI) Predicts Lymph Node (LN) Involvement in T1 Esophageal Adenocarcinoma (EAC). Invasion of Duplicated Muscularis Mucosae (MM) Has Similar Risk of LN Involvement as Mucosal Invasion. United States and Canadian Academy of Pathology, 2011. e-Pub 2011.
Kim JY, Correa AM, Swisher SG, Rice DC, Walsh GL, Vaporciyan AA, Mehran RJ, Roth JA, Bhutani M, Maru D, Welsh J, Ajani J, Rohren E, Hofstetter WL. Does the Timing of Esophagectomy After Neoadjuvant Chemoradiation Affect Outcome?. The Society of Thoracic Surgeons, 2011. e-Pub 2011.
Goodarzi M, Kanhere R, Corley L, A C, Ajani J, Swisher S, Hofstetter W, Rashid A, Maru D. Sox-9 Immunohistochemistry Demonstrates Abnormal Distribution of Gastrointestinal Stem Cells in Specialized and Non-Specialized Barrett's Mucosa. United States and Canadian Academy of Pathology, 2011. e-Pub 2011.
Blackmon SH, Zaheer I, Correa AM, Barroso AM, Ertan A. A Comparison of Photodynamic Therapy and Radiofrequency Ablation. Southern Thoracic Surgical Association, 2010. e-Pub 2010.
Blackmon SH, Stephens EH, Correa AM, Roth JA, Hofstetter W, Benjamin R, Mehran R, Swisher SG, Walsh GL, Vaporciyan AA. Progression following chemotherapy is a novel predictor of poor outcome following pulmonary metastasectomy in sarcoma patients. Journal of the American College of Surgeons 211(3):S35, 2010. e-Pub 2010.
Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Swisher S, Ajani JA. The influence of pretreatment body mass index on long-term prognosis of patients with esophageal carcinoma after surgery. American Society of Clinical Oncology, 2010. e-Pub 2010.
Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Roth JA, Vaporciyan AA, Peters JH, Watson TJ, Swisher SG. A Clinical Nomogram Predicting Pathologic Lymph-Node Involvement in Esophageal Cancer Patients. American Surgical Association, 2010. e-Pub 2010.
Kuroda S, Yokoyama T, Tam J, Scott AW, Shanker M, Correa AM, Roth JA, Sokolov K, Ramesh R. EGFR-targeted hybrid plasmonic magnetic nanoparticles induce autophagy and apoptosis through DNA damage in non-small cell lung cancer cells. American Association for Cancer Research, 2010. e-Pub 2010.
Kim MP, Hofstetter WL, Correa A, Rice DC, Roth JA, Walsh GL, Mehran RJ, Vaporciyan AA, Ajani JA, Maru DM, Chang JY, Marom EM, Macapinlac HA, Lee JH, Swisher SG. Pathologic T0N1 After Neoadjuvant Therapy and Surgery for Esophageal Cancer: An Orphan Status. The Society of Thoracic Surgeons, 2010. e-Pub 2010.
Kim MP, Correa A, Moran C, Erasmus J, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA. Resection of Lung Cancer in Lymphoma Survivors. The Society of Thoracic Surgeons, 2010. e-Pub 2010.
Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Swisher SG, Ajani JA. The Influence of Pretreatment Body Mass Index on Long-Term Prognosis of Patients With Esophageal Carcinoma After Surgery. Gastrointest Cancer Res, 2010. e-Pub 2010.
Gaur P, Hofstetter WL, Bekele NB, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Rice TW, Swisher SG. Staging of Gastroesophageal Adenocarcinomas: A Comparison Between Esophageal Staging, Gastric Staging, and a Novel Worldwide Esophageal Cancer Collaboration Staging System. Southern Thoracic Surgical Association, 2009. e-Pub 2009.
Swisher SG, Hofstetter WL, Komaki R, Correa AM, Erasmus J, Liao Z, Lee JH, Maru DM, Mehran RJ, Patel S, Phan A, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani J. Improved Long-Term Outcome with Chemoradiotherapy Strategies in Locoregionally Advanced Esophageal Cancer, 2009. e-Pub 2009.
Kountourakis P, Correa AM, Hayashi Y, Hofstetter WL, Komaki R, Vaporciyan AA, Rice DC, Walsh GL, Lee JH, Bhutani MS, Ross WA, Liao Z, Swisher SG, Ajani JA. In Patients with Clinical T2N0M0 Esophageal Cancer, Surgery First or Preoperative Chemoradiotherapy?. International Society of Gastrointestinal Oncology, 2009. e-Pub 2009.
Schier R, Mehran R, Smallwood A, Correa AM, Hightower C, Riedel B. Post-Exercise Reactive Hyperemia: A Novel Preoperative Risk Assessment Tool. Euroanesthesia, 2009. e-Pub 2009.
Maru DM, Correa AM, Tong Z, Wang H, Wu TT, Corley L, Krishnan S, Ajani JA, Swisher SG, Rashid A, Hofstetter WL, Guha S. Loss of Neutrophil Gelatinase Associated Lipocalin (NGAL) Expression in Esophageal Adenocarcinoma (EAC) Is Associated with Higher Pathologic Stage and Poor Survival. United States and Canadian Academy of Pathology, 2009. e-Pub 2009.
Hofstetter WL, Maru DM, Correa A, Shah N, Lee JH, Ajani JA, Erasmus J, Komaki R, Anandasabapathy S, Swisher SG. Salvage resection for esophageal adenocarcinoma after failed definitive chemoradiation. American Society of Clinical Oncology, 2009. e-Pub 2009.
Gaur P, Correa AM, Huang JL, Hofstetter W, Maru D, Mehran R, Roth JA, Vaporciyan AC, Walsh GL, Swisher SG. Correlation of endoscopic tumor length with lymph node involvement and poor long-term survival in esophageal cancer patients. American Society of Clinical Oncology, 2009. e-Pub 2009.
Blackmon S, Shah N, Correa AM, Benjamin R, Hofstetter W, Lev D, Pollock R, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran R. Complete Resection of Extra-Pulmonary Sarcomatous Metastases in Addition to Pulmonary Metastasectomy is Associated with Long-Term Survival. Society of Thoracic Surgeons, 2009. e-Pub 2009.
Schier R, Mehran R, Smallwood A, Correa AM, Riedel B. Prognostic Value of Preoperative Brachial Artery Reactivity Testing in Major Thoracic Surgery. American Society of Anesthesiologists, 2008. e-Pub 2008.
Schier R, Mehran R, Smallwood A, Aguilar J, Correa AM, Hernandez M. Comparative Study Evaluating Two Non-Invasive Surrogate Markers of Endothelial Function. American Society of Anesthesiologist, 2008. e-Pub 2008.
Norman PH, Vaporciyan AA, Rice DC, Correa AM. Rofecoxib provides significant improvement in survival following lung resection for cancer. American Society of Anesthesiologists, 2008. e-Pub 2008.
Vaporciyan A, Wang XS, Bashkar S, Correa A, Shi Q, Gning I, Hofstetter W, Rice D, Mehran R, Swisher S, Cleeland C. A Novel System for Measuring Longitudinal Postoperative Symptom Burden: Proof of Concept Comparing VATS versus Open Lobectomy. International Society For Minimally Invasive Cardiothoracic Surgery, 2008. e-Pub 2008.
Cen P, Ajani JA, Correa AM, Lee JH, Maru DM, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA. Adenocarcinoma of the lower esophagus with Barrett's or without Barrett's: differences in patients survival after preoperative chemoradiation. American Society of Clinical Oncology, 2008. e-Pub 2008.
Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele N, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Pisters KM, Rice DC, Walsh GL, Roth JA. Application of the Revised Lung Cancer Staging System (IASLC Staging Project) to a Cancer Center Population. American Association for Thoracic Surgery, 2008. e-Pub 2008.
Bolton WD, Hofstetter W, Francis A, Correa AM, Ajani JA, Bhutani B, Erasmus J, Komaki R, Maru D, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Impact of Tumor Length and Submucosal Involvement on the Long-Term Survival of pT1 Early Stage Esophageal Cancer. American Association for Thoracic Surgery, 2008. e-Pub 2008.
Bolton WD, Rice DC, Goodyear A, Correa AM, Erasmus J, Gokaslan Z, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, Rhines L. Long-Term Survival with Surgical Management for Superior Sulcus Tumor with Vertebral Resection. American Association for Thoracic Surgery, 2008. e-Pub 2008.
Mehran R, Shah N, Correa A, Vaporciyan A, Rice D, Hofstetter W, Walsh G, Benjamin R, Swisher S, Pollock R, Roth J. Pulmonary Metastatectomy In Sarcoma Patients With Extra-Thoracic Metastases. 18th World Congress of the World Society of Cardio-Thoracic Surgeons, 2008. e-Pub 2008.
Maru DM, Khurana H, Correa AM, Swisher SG, Ajani JA, Rashid A, Hofstetter WL. Clinicopathologic Features and Prognosis of High-Grade Neuroendocrine Carcinoma of Esophagus. United States and Canadian Academy of Pathology, 2008. e-Pub 2008.
Cen P, Hofstetter WL, Lee JH, Ross WA, Wu TT, Swisher SG, Davila M, Rashid A, Correa AM, Ajani JA. Value of Endoscopic Ultrasound Staging in Conjunction with Evaluation of Lymphovascular Invasion in Identifying Low-Risk Esophageal Carcinoma. Texas Society of Medical Oncology, 2007. e-Pub 2007.
Cen P, Hofstetter WL, Correa AM, Wu TT, Lee JH, Ross WA, Davilla M, Swisher SG, Fukami N, Maru D, Rashid A, Ajani JA. Lymphovascular Invasion as a Tool to Further Subclassify T1b Esophageal Adenocarcinoma. International Society of Gastrointestinal Oncology, 2007. e-Pub 2007.
Tetzlaff ED, Correa AM, Komaki R, Swisher S, Maru D, Ross W, Ajani JA. The Significance of Thromboembolic Phenomena Occurring Before and During Chemoradiotherapy for Localized Carcinoma of the Esophagus and Gastroesophageal Junction. International Society of Gastrointestinal Oncology, 2007. e-Pub 2007.
Javeri H, Arora R, Correa AM, Dixon D, Komaki R, Hofstetter W, Rice D, Walsh G, Vaporciyan A, Swisher SG, Lee JH, Bhutani M, Ross W, Liao Z, Maru D, Dekovich A, Tetzlaff ED, Erasmus J, Anandasabapathy S, Ajani JA. Comparison of the Outcomes of Patients With Localized Esophageal Carcinoma Receiving Bimodal versus Trimodal Therapy. International Society of Gastrointestinal Oncology (ISGIO), 2007. e-Pub 2007.
Liang J, Rashid A, Wu TT, Correa AM, Maru D, Corley LJ, Hofstetter WL, Swisher SG, Ajani JA, Hamilton SR, Wang H. High level of nucleolar expression of catalytic subunit of human telomerase reverse transcriptase (hTERT) is associated with better prognosis in patients with esophageal and esophagogastric junction adenocarcinomas. American Association for Cancer Research, 2007. e-Pub 2007.
Harada K, Estrella JS, Correa AM, Ma L, Dong X, Xu Y, Hofstette WL, Sudo K, Onodera H, Suzuki, Akihiro Suzuki K, Johnson RL, Zhenning Z, Song S, Ajani JA, Onodera H. American Associaation for Cancer Research. Tumor-associated macrophages infiltration highly associated with PD-L1 expression in gastric cancer, 2007. e-Pub 2007.
Blackmon SH, Rice DC, Correa AM, Ott DA, Putnam JB, Smythe WR, Vaporciyan AA, Walkes JC, Walsh GL, Reardon MJ. Results Of Radical Resection Of Primary Main Pulmonary Artery Sarcoma. World Congress on Heart Disease, 2007. e-Pub 2007.
Rice DC, Correa AM, Hofstetter WL, Mehran R, Swisher SG, Walsh GL, Vaporciyan AA, Roth JA. Recent Survival Trends for Clinically Staged Stage I Lung Cancer. The Society of Thoracic Surgeons, 2007. e-Pub 2007.
Blackmon SH, Rice DC, Correa AM, Hofstetter WL, Swisher SG, Mehran R, Vaporciyan AA, Walsh GL, Roth JA. Does a Gastrostomy Tube versus Jejunostomy tube Prior to Esophagectomy for Primary Esophageal Cancer Patients Have Additional Risk?. The Society of Thoracic Surgeons, 2007. e-Pub 2007.
Lu C, Wistuba I, Zhou X, Bekele BN, Putnam JB, Correa A, Mao L. Prognostic role of promoter hypermethylation of death-associated protein (DAP) kinase and p16 genes in early-stage non-small cell lung cancer. Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I 24(18S (June 20 Supplement), 2006):7216, 2006. e-Pub 2006.
Bakaeen F, Chu D, Correa AM, Rice D, McAllister R, Vaporciyan AA, Walsh G, Putnam JB, Swisher SG, Roth JA, Huh J, Smythe, WR. The Use of Aprotinin in Extrapleural Pneumonectomy: Effect on Hemostasis And Blood Product Utilization. Association of VA Surgeons Meeting, 2006. e-Pub 2006.
Tetzlaff ED, Correa AM, Baker J, Ensor J, Ajani JA. Impact on Survival of Thromboembolic Phenomena Occurring Before and During Protocol Chemotherapy in Patients With Advanced Gastroesophageal Adenocarcinoma. International Society of Gastrointestinal Oncology, 2006. e-Pub 2006.
Blackmon SH, Correa AM, Wynn B, Hofstetter W, Martin LW, Mehran R, Rice DC, Swisher SG, Walsh GL, Roth JA, Vaporciyan AA. Propensity Matched Analysis of Three Techniques for Intrathoracic Esophagogastric Anastomosis. Southern Thoracic Surgical Association, 2006. e-Pub 2006.
Hofstetter W, Correa AM, Ajani JA, Phan A, Komaki R, Zhonxing L, Wu TT, Blackmon S, Mehran RJ, Rice DC, Roth, JA, Walsh GL, Swisher SG. Proposed Modification of Nodal Status in AJCC Esophageal Cancer Staging System. Southern Thoracic Surgical Association, 2006. e-Pub 2006.
Wu TT, Chirieac LR, Abraham SC, Krasinskas A, Wang H, Rashid A, Correa AM, Hofstetter WL, Ajani JA, Swisher SG. Excellent interobserver agreement on grading the extent of residual carcinoma following preoperative chemoradiation in esophageal carcinoma: A reliable predictor for patient outcome. Mod Pathol 19(1):124A, 2006. e-Pub 2006.
Albarracin CT, Resetkoval E, Wang H, Anderson P, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Wu TT. Expression of Annexin A1 in esophageal and esophagoastric junction adenocarcinomas: association with poor outcome. Mod Pathol 19(1):100A, 2006. e-Pub 2006.
Tetzlaff ED, Correa AM, Baker J, Ensor J, Ajani JA. Incidence of thromboembolic events (TEEs) before and during chemotherapy of patients with advanced gastric and gastroesophageal junction carcinoma (AG-GEJC) on clinical trials. Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I 24(18S) (June 20 Supplement), 2006. e-Pub 2006.
Izzo JG, Luthra R, Wu TT, Correa AM, Luthra M, Anandasabapathy S, Clifford KS, Mien-Chie Hung C, Aggarwal B, Hittelman WN, Ajani JA. Molecular Mechanisms in Barrett’s Metaplasia and its Progression. Seminars in Oncology Volume 34, Issue , Supplement S1 (April 2007):S2-S6, 2006. e-Pub 2006.
Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter W, Liao Z, Komaki RR, Rashid A, Hamilton SR, Wu TT. Number of lymph nodes with metastasis predict survival in patients with esophageal or esophagogastric junction adenocarcinoma treated with preoperative chemoradiation. Journal of Clinical Oncology, 2005 ASCO Annual Meeting Proceedings 23 (16S) Part I of II (June 1 Supplement):319, 2005. e-Pub 2005.
Rohatgi P, Swisher S, Correa A, Wu TT, Liao Z, Komaki R, Walsh G, Vaporciyan A, Rice DC, Roth JA, Ajani JA. Degree of pathologic response after preoperative chemoradiotherapy correlates with failure patterns and outcome of patients with carcinoma of the esophagus. American Association for Cancer Research 46:1354, 2005. e-Pub 2005.
Malaisrie SC, Correa AM, Ajani JA, Komaki RR, Hofstetter WL, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. EUS-Identified Celiac Adenopathy Remains A Poor Prognostic Factor Despite Preoperative Chemoradiotherapy In Patients With Adenocarcinoma Of The Distal Esophagus. Proc. Am. Assoc. Thorac. Surg:102, 2005. e-Pub 2005.
Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. Society of Thoracic Surgeons, 2005. e-Pub 2005.
Agarwal B, Correa AM, Ho L. How early should pancreatic cancer be diagnosed to significantly improve survival?. Gastrointestinal Endoscopy 61(5):AB269, 2005. e-Pub 2005.
Malhotra U, Hittelman WN, Wu TT, Luthra R, Swisher S, Luthra M, Correa A, Aggarwal BB, Ajani JA, Izzo JG. Association of activated NF-kB, altered cyclin D1 and poor outcome in esophageal adenocarcinoma. American Association for Cancer Research 46:548, 2005. e-Pub 2005.
Wu X, Spitz MR, Gu J, Wu TT, Swisher SG, Liao Z, Correa AM, Liu J, Chiang SS, Milas L, Hittelman WN, Ajani JA. Genetic variations in chemotherapy drug action pathways modulate therapeutic response in esophageal cancer. American Association for Cancer Research 46:1451, 2005. e-Pub 2005.
Martin LW, Correa AM, Dolormente M, Francisco R, Martin F, Sarabia AJ, Hong WK, Smythe WR, Putnam Jr JB, Hofstetter W, Rice DC, Vaporciyan AA, Swisher SG, Walsh GL, Roth JA. Outcomes For Resected Stage IIIA Non-Small Cell Lung Cancer Over 15 Years at a Single Institution. Proc. Am. Assoc. Thorac. Surg:72, 2005. e-Pub 2005.
Martin LW, Swisher SG, Hofstetter W, Correa AM, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Intrathoracic Leaks Following Esophagectomy Are No Longer Associated With Increased Mortality. Proc. Am. Surg. Assoc:64, 2005. e-Pub 2005.
Choi I, An C, Swisher SG, Correa AM, Ajani JA, Rashid A, Hamilton SR, Wu TT. Frequent CpG island methylation in resected esophageal adenocarcinomas. Amercian Association for Cancer Research, 2005. e-Pub 2005.
Herrera LJ, AM C, Vaporciyan AA, Hofstetter WL, Rice DC, Swisher SG, Walsh GL, Roth JA, Mehran RJ. Increased Risk of Aspiration and Pulmonary Complications after Lung Resection in Head and Neck Cancer Patients. Society of Thoracic Surgeons, 2005. e-Pub 2005.
Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Swisher SG. The Addition of Induction Chemotherapy to Preoperative Concurrent Chemoradiotherapy Improves Tumor Response in Patients with Esophageal Adenocarcinoma. Western Thoracic Surgical Association, 2005. e-Pub 2005.
Liu L, Hofstetter W, Rashid A, Swisher S, Correa A, Hamilton S, Wu TT. Significance of the Depth of Tumor Invasion in Early (T1) Esophageal Adenocarcinoma. Mod Pathol 18(1):110A, 2005. e-Pub 2005.
Stevens C, Rice D, Forster K, Liao Z, Guerrero T, Correa A, Vaporciyan A, Smythe WR. Extrapleural pneumonectomy followed by IMRT: Results of a phase I/II study. Journal of Clinical Oncology, 2005 ASCO Annual Meeting Proceedings 23(16S) Part I of II (June 1 Supplement), 2005. e-Pub 2005.
Liao Z, Liu H, Swisher SG, Wang L, Wu TT, Correa AM, Roth J, Cox JD, Komaki R, Ajani JA, Wei Q. Polymorphisms of Thymidylate Synthase Gene Predict Local Or Distant Recurrence After Preoperative Chemoradiation In Esophageal Cancer. Proc Semin Oncol, 2004. e-Pub 2004.
Wu TT, Chirieac LR, Swisher SG, Komaki RU, Correa AM, Roth J, Rashid A, Hamilton SR, Ajani JA. Post-chemoradiation surgical pathologic stage accurately predicts outcome of patients with esophageal or gastroesophageal junction carcinoma. Proc. Am. Soc. Clin. Oncol:319, 2004. e-Pub 2004.
Swisher SG, Erasmus J, Maish M, Correa AM, Ajani JA, Komaki RR, Cox J, Lee HK, Macaplinac H, Putnam JB, Rice D, Smythe WR, Vaporciyan AA, Walsh GL, Hong D, Wu TT, Roth JA. PET predicts pathologic response and long-term survival following preoperative chemoradiation in esophageal cancer. Gastrointestinal Cancers Symposium, ASCO, 2004. e-Pub 2004.
McCann II UG, Correa AM, Walsh G. Surgical management of locally advanced lung cancer: The M. D. Anderson Experience 2004. Michael E. DeBakey International Surgical Society, 2004. e-Pub 2004.
Agarwal B, Gogia S, Correa AM, Ho L, Collins BT. Malignant mediastinal lymphadenopathy in patients with pancreatobiliary cancer. Gastrointestinal Endoscopy 59(5):P224, 2004. e-Pub 2004.
Gogia S, Bismar M, Collins BT, Correa AM, Ho L, Agarwal B. Is it worthwhile to evaluate pancreas in patients undergoing staging EUS for esophageal cancer?. Gastrointestinal Endoscopy 59(5):P215, 2004. e-Pub 2004.
Agarwal B, Bismar M, Gogia S, Ho L, Correa AM, Collins BT. Pre-operative identification of malignancy in cystic lesions of pancreas by EUS-FNA. Gastrointestinal Endoscopy 59(5):P229, 2004. e-Pub 2004.
Swisher SG, Maish M, Erasmus J, Correa AM, Ajani J, Bresalier R, Komaki R, Macaplinac H, Munden R, Putnam JB, Rice D, Smythe WR, Vaporciyan A, Walsh G, Wu TT, Roth J. Utility of PET, CT Scan and EUS to Identify Pathologic Responders in Esophageal Cancer. Proc. Soc. Thorac. Surg:170-171, 2004. e-Pub 2004.
Chirieac LR, Swisher SG, Ajani JA, Komaki RR, Correa AM, Roth J, Rashid A, Hamilton SR, Wu TT. Residual Tumor Status Predicts the Survival Of Patients with Treated Esophageal Carcinoma. Mod Pathol 17(1):112A, 2004. e-Pub 2004.
Pan J, Ceron TL, Babenko IM, Wu TT, Swisher S, Correa AM, Ajani J, Hittelman WN, Izzo JG. Cyclin D1 A870G polymorphism is associated with early onset of Barrett's adenocarcinoma. Proc Amer Assoc Cancer Res 45:914, 2004. e-Pub 2004.
Rice DC, Swisher SG, Correa AM, Ajani JA, Putnam JB, Smythe WR, Walsh GL, Vaporciyan AA, Roth JA. Induction Chemoradiotherapy Prior To Esophagectomy In Elderly Patients Is Not Associated With Increased Morbidity. Proc. Soc. Thorac. Surg:266-267, 2004. e-Pub 2004.
Pan J, Hittelman WN, Wu TT, Bresalier R, Swisher SG, Correa AM, Ajani J, Izzo JG. Cyclin D1 A870G polymorphism is associated with early onset and shorter disease-free survival in esophageal adenocarcinoma. Proc Int Soc Gastrointest Oncol, 2004. e-Pub 2004.
Agarwal B, Swisher S, Kelly K, Ajani J, Komaki R, Putnam Jr JB, Molke KL, Lehmann J, Bismar MM, Walsh GL, Correa AM, Ho L, Liao Z, Lynch PM, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Pre-operative chemoradiation downstages esophageal adenocarcinoma and abolishes differences in post-operative survival. AGA/DDW, 2003. e-Pub 2003.
Putnam JB, Roberson SL, Lewin JS, Correa AM, Swisher SG, Walsh GL, Rice DC, Vaporciyan AA, Roth JA, Smythe WR. Risk analysis for pneumonia following esophagectomy. The Society of Thoracic Surgeons:258, 2003. e-Pub 2003.
Jr PJ, Correa AM, Swisher SG, Smythe WR, Rice DC, Roth JA, Vaporciyan AA, Walsh GL. A model for prospective quality improvement in thoracic surgical oncology. Texas Surg. Soc, 2003. e-Pub 2003.
Onn A, Marom E, Isobe T, Choe DH, Correa AM, Putnam JB, Herbst RS. Tumor Caviation is Associated with Epidermal Growth Factor Expression and is a Predictor of Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer. Chest Meeting Abstracts 124:102S-a, 2003. e-Pub 2003.
Onn A, Correa AM, Gilcrease M, Moran C, Roach JS, Isobe T, Bucana CD, Hong WK, Putnam JB, Herbst RS. Epidermal Growth Factor Receptor, HER2, and c-Kit as predictors of outcome in stage I non-small cell lung cancer. Proc Am Soc Clin Oncol 22:635, 2003. e-Pub 2003.
Vaporciyan A, Correa AM, Rice D, Roth J, Smythe WR, Swisher S, Walsh G, Jr PJ. Identification of Risk factors associated with atrial fibrillation after thoracic surgery: analysis of 2,588 patients. Proc.Am.Assoc.Thorac.Surg 78, 2003. e-Pub 2003.
Agarwal B, Swisher S, Ajani J, Kelly K, Fanning C, Komaki RR, Jr PJ, Abu-Hamada I, Molke KL, Walsh GL, Correa AM, Ho L, Liao Z, Lynch PM, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Persistent malignant lymphadenopathy after preoperative chemoradiation identifies patients with poor postoperative survival. Gastrointestinal Endoscopy 56 (4) Supplement 1:S110, 2002. e-Pub 2002.
Agarwal B, Swisher SG, Kelly K, Ajani J, Komaki RR, Putnam Jr JB, Molke KL, Lehmann J, Bismar MM, Walsh GL, Correa AM, Ho L, Liao Z, Lynch PM, Rice D, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Determinants of response to chemoradiation in patients with esophageal cancer. Proc Am Gastroenterol Assoc, 2002. e-Pub 2002.
Agarwal B, Swisher SG, Kelly K, Lynch P, Ajani J, Komaki RR, Putnam Jr JB, Molke KL, Lehmann J, Bismar MM, Walsh GL, Correa AM, Ho L, Kelly J, Liao Z, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Role of EUS lymph node assessment after pre-operative chemoXRT in esophageal cancer patients. Proc Am Gastroenterol Assoc, 2002. e-Pub 2002.
Hofstetter W, Swisher SG, Correa AM, Jr PJ, Ajani JA, Dolormente M, Francisco R, Komaki RR, Lara A, Martin F, Rice DC, Sarabia AJ, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Evolving treatment outcomes of resected esophageal cancer over three decades for 951 patients at a single institution. Proc. Am. Surg. Assoc:100-101, 2002. e-Pub 2002.
Vaporciyan AA, Rice DC, Correa AM, Walsh GL, Swisher SG, Smythe WR, Putnam JB, Roth JA. Resection of advanced thoracic malignancies requiring cardiopulmonary bypass (CPB). Proc. Europ. Assoc. Cardiovasc. Thorac. Surg 22:47-52, 2001. e-Pub 2001.
Swisher SG, Roth JA, Komaki R, Hicks M, Ro J, Hong WK, Ahrar K, Correa AM, Dolomente M, Dreiling L, Fang B, Fossella F, Francisco R, Glisson B, Herbst R, Huaringa A, Gu J, Kelly J, Kemp B, Khuri F, Kurie J, Lee J, Lee JS, Liao Z, Merritt J, Morice R, Morello F, Mosheim M, Munden R, Papadimitrakopoulou V, Pisters K, Putnam JB, Sarabia AJ, Shelton T, Stevens C, Shin D, Smythe WR, Vaporciyan A, Walsh G, Yin M, Yver A. Induction of pro-apoptotic mediators and tumor regression following intratumoral delivery of adenoviral p53 (RPR/INGN 201) and radiation therapy in patients with non-small cell lung cancer (NSCLC). Proc. Am. Soc. Clin. Oncol 20:257a. Abstract No: 1024, 2001. e-Pub 2001.
Deboever N, Correa A, Feldman H, Eisenberg MA, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Wash GL, Hofstetter WL. Early Intervention of High Output Chyle Leak following Esophagectomy is Associated with Improved Survival. The Society of Thoracic Surgeons 2023 - 59th Annual Meeting.
Kassab C, Mitchell K, Correa A, Eisenberg M, Ries S, Antonoff M, Mehran R, Rajaram R, Rice D, Swisher S, Vaporciyan A, Walsh G, Hofstetter W. Successful management of post esophagectomy anastomotic leak nullifies its effect on long term survival. AATS 2023.
Camacho L, Elmorsi R, Krijgh DD, Tilney GS, Lyu H, Traweek RS, Witt RG, Roubaud MS, Correa AM, Roland CL, Mericli AF. Impact of Social Vulnerability and Area Deprivation Index on Outcomes of Lower Extremity Sarcoma Reconstruction. Plastic Surgery Research Council 2024-69th Annual Meeting.
Camacho L, Elmorsi R, Krijgh DD, Tilney GS, Lyu H, Traweek RS, Witt RG, Roubaud MS, Correa AM, PhD, Roland CL, Mericli AF. Reconstruction of the foot and ankle after soft tissue sarcoma resection. Plastic Surgery Research Council 2024.
Camacho L, Elmorsi R, Krijgh DD, Tilney GS, Lyu H, Traweek RS, Witt RG, Roubaud MS, Correa AM, Roland CL, Mericli AF. Outcomes of Free Tissue Transfer in Lower Extremity Soft Tissue Sarcoma Reconstruction: An Analysis at a Quaternary Cancer Center. Plastic Surgery Research Council 2024.
Ries SA, Eisenberg MA, Kassab C, Correa A, Mitchell K, Antonoff MB, Mehran RJ, Rice DC, Rajaram R, Swisher SG, Walsh GL, Vaporciyan AA, Hofstetter WL. Endoscopy Suite or Operating Room? A Comparative Study of Treatment Approaches for Anastomotic Leaks After Esophagectomy. International Thoracic Surgical Oncology Summit 2024.
Camacho, Luis. The Impact of Verzenio on Post-Mastectomy Breast Reconstruction. Plastic Surgery The Meeting 2024 - PSTM 2024.
Camacho L. Retrorectus Mesh Implementation in Autologous Breast Reconstruction: A Comparative Analysis of Surgical Outcomes. Plastic Surgery The Meeting 2024 - PSTM 2024.
Deboever N, Correa A, Feldman H, Eisenberg M, Antonoff M, Mehran R, Rajaram R, Rice D, Roth J, Sepesi B, Swisher S, Walsh G, Hofstetter W. Should Octreotide be Used in the Management of Chylothorax following Esophagectomy? Cohort Study and Systematic Review of the Literature. The Society of Thoracic Surgeon 2023 - 59th Annual Meeting.
Rice D, Mehran R, Correa A, Antonoff M, Hofstetter W, Roth J, Sepesi B, Swisher S, Walsh G, Vaporciyan A. Is There Any Value To Robotic Assisted Lobectomy? A Single Institution Comparison With 631 Contemporaneous VATS And Open Lobectomies. American Association for Thoracic Surgery 2017.
Correa AM. The Impact of Adjuvant Therapy on Pathologic T1N1 Esophageal Adenocarcinoma Outcomes: A National Cancer Database Propensity-Matched Analysis. 106th Annual Meeting | May 2 - 5, 2026.

Less

CV information above last modified March 31, 2026

Arlene M. Correa, Ph.D.

About Dr. Arlene M. Correa

Present Title & Affiliation

Primary Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Experience & Service

Faculty Academic Appointments

Other Professional Positions

Honors & Awards

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Review Articles

Professional Educational Materials

Abstracts

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

Arlene M. Correa, Ph.D.

About Dr. Arlene M. Correa

Present Title & Affiliation

Primary Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Experience & Service

Faculty Academic Appointments

Other Professional Positions

Honors & Awards

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Review Articles

Professional Educational Materials

Abstracts

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Shop UT MD Anderson